<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2026"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2026"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:mrai="http://marpai.com/20260630"
  xmlns:srt="http://fasb.org/srt/2026"
  xmlns:us-gaap="http://fasb.org/us-gaap/2026"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="mrai-20260630.xsd" xlink:type="simple"/>
    <context id="cref_1864859878">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_917344505">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mrai:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-07-29</instant>
        </period>
    </context>
    <context id="cref_388777331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mrai:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-07-29</startDate>
            <endDate>2026-07-29</endDate>
        </period>
    </context>
    <context id="cref_678316177">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_547452146">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mrai:SettlementAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2028-01-03</startDate>
            <endDate>2028-01-03</endDate>
        </period>
    </context>
    <context id="cref_2127661120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mrai:SettlementAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2028-01-03</instant>
        </period>
    </context>
    <context id="cref_1934857388">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mrai:SettlementAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2028-01-03</startDate>
            <endDate>2028-01-03</endDate>
        </period>
    </context>
    <context id="cref_1444181199">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mrai:SettlementAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2027-07-01</startDate>
            <endDate>2027-07-01</endDate>
        </period>
    </context>
    <context id="cref_94216187">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mrai:SettlementAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2027-01-01</startDate>
            <endDate>2027-01-01</endDate>
        </period>
    </context>
    <context id="cref_1917496726">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mrai:SettlementAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-07-01</startDate>
            <endDate>2026-07-01</endDate>
        </period>
    </context>
    <context id="cref_1329316492">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mrai:SettlementAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-02-05</startDate>
            <endDate>2026-02-05</endDate>
        </period>
    </context>
    <context id="cref_78158019">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mrai:SettlementAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-02-05</startDate>
            <endDate>2026-02-05</endDate>
        </period>
    </context>
    <context id="cref_35673841">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mrai:SettlementAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-02-05</instant>
        </period>
    </context>
    <context id="cref_247623300">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mrai:SettlementAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-09-22</startDate>
            <endDate>2025-09-22</endDate>
        </period>
    </context>
    <context id="cref_156869995">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="cref_685214448">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_2099918223">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="cref_1318692929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_1876967377">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_696692331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="cref_968639710">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="cref_560512737">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_204867774">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-07-09</instant>
        </period>
    </context>
    <context id="cref_1870440128">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
        </entity>
        <period>
            <instant>2026-05-13</instant>
        </period>
    </context>
    <context id="cref_765845676">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mrai:ThirdPartyAdministratorServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_1577086537">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mrai:ThirdPartyAdministratorServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_1353931839">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mrai:ThirdPartyAdministratorServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_1016381307">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mrai:ThirdPartyAdministratorServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-29</instant>
        </period>
    </context>
    <context id="cref_302890046">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
        </entity>
        <period>
            <instant>2026-03-09</instant>
        </period>
    </context>
    <context id="cref_1920807326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
        </entity>
        <period>
            <startDate>2026-03-09</startDate>
            <endDate>2026-03-09</endDate>
        </period>
    </context>
    <context id="cref_1994068421">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
        </entity>
        <period>
            <startDate>2026-02-12</startDate>
            <endDate>2026-02-12</endDate>
        </period>
    </context>
    <context id="cref_1972424199">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">mrai:MarpaiWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="cref_757566738">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">mrai:MarpaiWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="cref_429591522">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">mrai:MarpaiWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="cref_923970876">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">mrai:MarpaiWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="cref_1516893171">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">mrai:MarpaiWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="cref_1585372191">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">mrai:MarpaiWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="cref_1447836475">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">mrai:MarpaiWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="cref_1050108937">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">mrai:MarpaiWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_1247677442">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">mrai:MarpaiWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_877497746">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">mrai:MarpaiWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_1887911658">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">mrai:MarpaiWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_684365930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">mrai:MarpaiWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_1680470473">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">mrai:MarpaiWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_1610511180">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">mrai:MarpaiWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_56077519">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_1518419059">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_403226097">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="cref_981354773">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_1688485009">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_1099064921">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-05-29</startDate>
            <endDate>2026-05-29</endDate>
        </period>
    </context>
    <context id="cref_1381851302">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-05-21</startDate>
            <endDate>2026-05-21</endDate>
        </period>
    </context>
    <context id="cref_523754851">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
        </entity>
        <period>
            <startDate>2026-04-16</startDate>
            <endDate>2026-04-16</endDate>
        </period>
    </context>
    <context id="cref_1796326046">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-16</startDate>
            <endDate>2026-04-16</endDate>
        </period>
    </context>
    <context id="cref_1752949693">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-03-13</startDate>
            <endDate>2026-03-13</endDate>
        </period>
    </context>
    <context id="cref_1387594773">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_1202730097">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-05-05</startDate>
            <endDate>2026-05-05</endDate>
        </period>
    </context>
    <context id="cref_1149706590">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
        </entity>
        <period>
            <startDate>2026-02-02</startDate>
            <endDate>2026-02-02</endDate>
        </period>
    </context>
    <context id="cref_1170613260">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-02-02</startDate>
            <endDate>2026-02-02</endDate>
        </period>
    </context>
    <context id="cref_2125158039">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-02-02</startDate>
            <endDate>2026-02-02</endDate>
        </period>
    </context>
    <context id="cref_87961422">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-03-07</startDate>
            <endDate>2025-03-07</endDate>
        </period>
    </context>
    <context id="cref_1787917770">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-28</startDate>
            <endDate>2025-01-28</endDate>
        </period>
    </context>
    <context id="cref_717754146">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mrai:StockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-28</startDate>
            <endDate>2025-01-28</endDate>
        </period>
    </context>
    <context id="cref_1098369590">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-28</startDate>
            <endDate>2025-01-28</endDate>
        </period>
    </context>
    <context id="cref_1743034571">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_408305594">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_308193255">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="cref_1372569509">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="cref_1299040678">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_1398839902">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
        </entity>
        <period>
            <startDate>2025-12-31</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="cref_1448377746">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mrai:TwentyTwentyGlobalIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_299327299">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mrai:TwentyTwentyFourGlobalIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-06</instant>
        </period>
    </context>
    <context id="cref_539106327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mrai:TwentyTwentyFourGlobalIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_799465022">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mrai:RestrictedStockAwardsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mrai:TwentyTwentyGlobalIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-05-31</instant>
        </period>
    </context>
    <context id="cref_2077819978">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mrai:TwentyTwentyGlobalIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-31</startDate>
            <endDate>2023-05-31</endDate>
        </period>
    </context>
    <context id="cref_735862645">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mrai:ThirdPartyAdministratorServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="cref_1346636084">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mrai:ThirdPartyAdministratorServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_267200198">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mrai:CaptiveInsuranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="cref_1074043652">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mrai:ThirdPartyAdministratorServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="cref_1261990852">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mrai:ThirdPartyAdministratorServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_922798872">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
        </entity>
        <period>
            <instant>2026-06-15</instant>
        </period>
    </context>
    <context id="cref_57105684">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mrai:ServicesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-15</instant>
        </period>
    </context>
    <context id="cref_1277293661">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-07-29</instant>
        </period>
    </context>
    <context id="cref_2006171306">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-07-29</startDate>
            <endDate>2026-07-29</endDate>
        </period>
    </context>
    <context id="cref_1560543668">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mrai:AXAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_1249440349">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mrai:AXAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_61579801">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_335727296">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mrai:DebenturesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_1678445717">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mrai:DebenturesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_1624743679">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2028-04-15</startDate>
            <endDate>2028-04-15</endDate>
        </period>
    </context>
    <context id="cref_1303376523">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2027-03-31</startDate>
            <endDate>2027-03-31</endDate>
        </period>
    </context>
    <context id="cref_486616208">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mrai:DebenturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_2004002158">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_1828027660">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mrai:DebenturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-01-17</instant>
        </period>
    </context>
    <context id="cref_1312370311">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mrai:DebenturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-30</instant>
        </period>
    </context>
    <context id="cref_576166649">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mrai:DebenturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-12-30</startDate>
            <endDate>2024-12-30</endDate>
        </period>
    </context>
    <context id="cref_1030399269">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mrai:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-21</startDate>
            <endDate>2024-06-21</endDate>
        </period>
    </context>
    <context id="cref_428381758">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mrai:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-15</startDate>
            <endDate>2024-04-15</endDate>
        </period>
    </context>
    <context id="cref_1422776500">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mrai:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-15</instant>
        </period>
    </context>
    <context id="cref_1226747563">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="cref_1534084021">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="cref_717232960">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="cref_1731395949">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_1046745539">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="cref_781661425">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_1940157768">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_939099532">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">mrai:TwoCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="cref_1975347265">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">mrai:OneCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="cref_970781207">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">mrai:TwoCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_283139205">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">mrai:OneCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_1364625654">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_2144516316">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ExtinguishmentOfDebtAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_1112506559">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ExtinguishmentOfDebtAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_350394481">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ExtinguishmentOfDebtAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_1330789163">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="cref_1672293235">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="cref_279763595">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="cref_1681429834">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="cref_656402117">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="cref_1489525931">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="cref_1318945957">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="cref_815244211">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="cref_94573302">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_833101924">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_1215524900">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_1713304212">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_1130559254">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_1659572957">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_385193611">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_967157915">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_1373149467">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="cref_2104063504">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="cref_837610684">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="cref_659268312">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="cref_1228721679">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="cref_1824153813">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="cref_223431024">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_1715742340">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_984413423">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_94868961">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_1529656207">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_322972255">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_1103525179">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_2053830456">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_16326568">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
        </entity>
        <period>
            <instant>2026-08-13</instant>
        </period>
    </context>
    <context id="cref_61033215">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_161598891">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_1629343917">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="cref_1160633274">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_161047949">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_1856378622">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="cref_237404511">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="cref_898928874">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mrai:CaptiveInsuranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_1012969921">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="cref_201458801">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mrai:CaptiveInsuranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_598184240">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mrai:CaptiveInsuranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="cref_456773170">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_972350248">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_602010912">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001844392</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <unit id="uref_917344505">
        <measure>shares</measure>
    </unit>
    <unit id="uref_388777331">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="uref_2099918223">
        <measure>pure</measure>
    </unit>
    <unit id="uref_1231523903">
        <measure>mrai:segment</measure>
    </unit>
    <unit id="uref_1972424199">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="cref_1864859878"
      id="fc_500476876"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="cref_696692331"
      id="fc_283698779"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="cref_61033215"
      id="fc_61033215"
      unitRef="uref_917344505"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="cref_61033215"
      id="fc_876701048"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="cref_161598891"
      id="fc_161598891"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="cref_984413423"
      id="fc_1778046852"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="cref_223431024"
      id="fc_931886818"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="cref_161598891"
      id="fc_199841666"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="cref_984413423"
      id="fc_955348812"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="cref_1715742340"
      id="fc_496284277"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="cref_223431024"
      id="fc_1735122560"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="cref_1864859878"
      id="fc_635142311"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <mrai:StockIssuedDuringPeriodValueIssuedForService
      contextRef="cref_1629343917"
      id="fc_1629343917"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <mrai:StockIssuedDuringPeriodValueIssuedForService
      contextRef="cref_837610684"
      id="fc_1352221239"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <mrai:StockIssuedDuringPeriodValueIssuedForService
      contextRef="cref_1373149467"
      id="fc_1979224920"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="cref_1160633274"
      id="fc_1160633274"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="cref_1731395949"
      id="fc_460337688"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="cref_1713304212"
      id="fc_1995936409"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="cref_161598891"
      id="fc_792740474"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="cref_984413423"
      id="fc_611781884"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="cref_1715742340"
      id="fc_943033577"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="cref_161047949"
      id="fc_161047949"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="cref_1856378622"
      id="fc_1856378622"
      unitRef="uref_917344505"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="cref_1856378622"
      id="fc_1728783504"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="cref_1629343917"
      id="fc_1739517320"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="cref_837610684"
      id="fc_672274688"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="cref_1373149467"
      id="fc_2076101024"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="cref_1629343917"
      id="fc_1644704108"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <mrai:VendorFinancingAdvance
      contextRef="cref_560512737"
      id="fc_1259555020"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="cref_678316177"
      id="fc_1621430476"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="cref_678316177"
      id="fc_801044652"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="cref_968639710"
      id="fc_267849584"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="cref_837610684"
      id="fc_297216826"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="cref_2104063504"
      id="fc_1748220145"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="cref_1373149467"
      id="fc_2014560790"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="cref_696692331"
      id="fc_1028049731"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="cref_1160633274"
      id="fc_670016614"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="cref_1731395949"
      id="fc_46081083"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="cref_1130559254"
      id="fc_1887393019"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="cref_237404511"
      id="fc_237404511"
      unitRef="uref_917344505"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="cref_237404511"
      id="fc_1657246755"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInDueToRelatedParties
      contextRef="cref_968639710"
      id="fc_85677194"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="cref_678316177"
      id="fc_69475176"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="cref_678316177"
      id="fc_519202184"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <mrai:ProceedsFromIssuanceOfRelatedPartyPromissoryNotes
      contextRef="cref_968639710"
      id="fc_1338466311"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="cref_678316177"
      id="fc_1049362906"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="cref_678316177"
      id="fc_893806272"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <mrai:PaymentsToSellerForAcquisition
      contextRef="cref_678316177"
      id="fc_906772147"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:CapitalizedComputerSoftwareNet
      contextRef="cref_685214448"
      id="fc_1199039503"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="cref_560512737"
      id="fc_1595692465"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense
      contextRef="cref_678316177"
      id="fc_718799904"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense
      contextRef="cref_968639710"
      id="fc_675325791"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense
      contextRef="cref_678316177"
      id="fc_402515611"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1
      contextRef="cref_678316177"
      id="fc_2024516547"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1
      contextRef="cref_678316177"
      id="fc_1254963063"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1
      contextRef="cref_968639710"
      id="fc_979518578"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1
      contextRef="cref_678316177"
      id="fc_201969355"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:PaymentsForLossesAndLossAdjustmentExpense
      contextRef="cref_678316177"
      id="fc_2010329833"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="cref_685214448"
      id="fc_830608628"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="cref_898928874"
      id="fc_898928874"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="cref_560512737"
      id="fc_683036858"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="cref_678316177"
      id="fc_875834485"
      unitRef="uref_917344505"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="cref_678316177"
      id="fc_2089508952"
      unitRef="uref_1972424199"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="cref_678316177"
      id="fc_613335784"
      unitRef="uref_917344505"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="cref_678316177"
      id="fc_767358761"
      unitRef="uref_1972424199"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="cref_685214448"
      id="fc_1824740326"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="cref_685214448"
      id="fc_1728476536"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="cref_678316177"
      id="fc_708546188"
      unitRef="uref_917344505"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="cref_678316177"
      id="fc_1100784233"
      unitRef="uref_1972424199"
      xsi:nil="true"/>
    <mrai:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedNumberOfShares
      contextRef="cref_678316177"
      id="fc_970156303"
      unitRef="uref_917344505"
      xsi:nil="true"/>
    <mrai:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageGrantDateFairValue
      contextRef="cref_678316177"
      id="fc_1957172883"
      unitRef="uref_1972424199"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
      contextRef="cref_1887911658"
      id="fc_1058397457"
      unitRef="uref_917344505"
      xsi:nil="true"/>
    <mrai:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeGranted
      contextRef="cref_1887911658"
      id="fc_1677790641"
      unitRef="uref_1972424199"
      xsi:nil="true"/>
    <mrai:ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceGranted
      contextRef="cref_1887911658"
      id="fc_2088495238"
      unitRef="uref_1972424199"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
      contextRef="cref_1887911658"
      id="fc_950521858"
      unitRef="uref_917344505"
      xsi:nil="true"/>
    <mrai:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercised
      contextRef="cref_1887911658"
      id="fc_1993400703"
      unitRef="uref_1972424199"
      xsi:nil="true"/>
    <mrai:ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercised
      contextRef="cref_1887911658"
      id="fc_1184182678"
      unitRef="uref_1972424199"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
      contextRef="cref_923970876"
      id="fc_1114912567"
      unitRef="uref_917344505"
      xsi:nil="true"/>
    <mrai:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeGranted
      contextRef="cref_923970876"
      id="fc_241447946"
      unitRef="uref_1972424199"
      xsi:nil="true"/>
    <mrai:ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceGranted
      contextRef="cref_923970876"
      id="fc_1600341133"
      unitRef="uref_1972424199"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
      contextRef="cref_923970876"
      id="fc_788704778"
      unitRef="uref_917344505"
      xsi:nil="true"/>
    <mrai:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercised
      contextRef="cref_923970876"
      id="fc_875979209"
      unitRef="uref_1972424199"
      xsi:nil="true"/>
    <mrai:ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercised
      contextRef="cref_923970876"
      id="fc_1057347459"
      unitRef="uref_1972424199"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="cref_1012969921"
      id="fc_1012969921"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="cref_717232960"
      id="fc_37217006"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="cref_1681429834"
      id="fc_458687076"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="cref_1012969921"
      id="fc_2098503559"
      unitRef="uref_917344505"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="cref_1012969921"
      id="fc_162885039"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="cref_717232960"
      id="fc_590133827"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="cref_656402117"
      id="fc_1320673782"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="cref_1681429834"
      id="fc_1539043330"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="cref_968639710"
      id="fc_1611172617"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="cref_1160633274"
      id="fc_1418415931"
      unitRef="uref_917344505"
      xsi:nil="true"/>
    <mrai:StockIssuedDuringPeriodValueIssuedForService
      contextRef="cref_1160633274"
      id="fc_684057926"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <mrai:StockIssuedDuringPeriodValueIssuedForService
      contextRef="cref_1731395949"
      id="fc_1734957025"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <mrai:StockIssuedDuringPeriodValueIssuedForService
      contextRef="cref_1713304212"
      id="fc_1591635485"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="cref_1012969921"
      id="fc_1585020833"
      unitRef="uref_917344505"
      xsi:nil="true"/>
    <mrai:StockIssuedDuringPeriodValueNewIssue
      contextRef="cref_1012969921"
      id="fc_1406036782"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <mrai:StockIssuedDuringPeriodValueNewIssue
      contextRef="cref_1681429834"
      id="fc_1513005303"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="cref_1012969921"
      id="fc_377858442"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="cref_717232960"
      id="fc_1408998545"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="cref_656402117"
      id="fc_1761496539"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="cref_237404511"
      id="fc_614547773"
      unitRef="uref_917344505"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="cref_237404511"
      id="fc_1698832895"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="cref_968639710"
      id="fc_959381916"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:RepaymentsOfRelatedPartyDebt
      contextRef="cref_968639710"
      id="fc_1459208792"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <mrai:ProceedsFromVendorFinancingAdvance
      contextRef="cref_968639710"
      id="fc_188621476"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromRelatedPartyDebt
      contextRef="cref_968639710"
      id="fc_689771415"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="cref_678316177"
      id="fc_2135621129"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="cref_94868961"
      id="fc_1527964499"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense
      contextRef="cref_1864859878"
      id="fc_1032511269"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense
      contextRef="cref_696692331"
      id="fc_1151601350"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense
      contextRef="cref_1864859878"
      id="fc_817278067"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1
      contextRef="cref_1864859878"
      id="fc_293986317"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1
      contextRef="cref_696692331"
      id="fc_796188153"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1
      contextRef="cref_1864859878"
      id="fc_713713788"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1
      contextRef="cref_696692331"
      id="fc_727231070"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1
      contextRef="cref_1864859878"
      id="fc_1866867441"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1
      contextRef="cref_696692331"
      id="fc_1834583089"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:PaymentsForLossesAndLossAdjustmentExpense
      contextRef="cref_1864859878"
      id="fc_1425340663"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:PaymentsForLossesAndLossAdjustmentExpense
      contextRef="cref_696692331"
      id="fc_928778361"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="cref_685214448"
      id="fc_1118269202"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="cref_201458801"
      id="fc_201458801"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="cref_598184240"
      id="fc_598184240"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="cref_456773170"
      id="fc_456773170"
      unitRef="uref_917344505"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="cref_456773170"
      id="fc_748199565"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration contextRef="cref_678316177" id="fc_309145295">http://fasb.org/srt/2026#ChiefExecutiveOfficerMember</us-gaap:SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="cref_972350248"
      id="fc_972350248"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <dei:SecurityExchangeName contextRef="cref_678316177" id="fc_424939066">NONE</dei:SecurityExchangeName>
    <us-gaap:CommitmentsAndContingencies
      contextRef="cref_685214448"
      id="fc_1400046612"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="cref_560512737"
      id="fc_996105678"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="cref_685214448"
      id="fc_1904529266"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="cref_560512737"
      id="fc_1328233132"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="cref_1864859878"
      id="fc_1122586340"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="cref_696692331"
      id="fc_1969280221"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:DepreciationAndAmortization
      contextRef="cref_1864859878"
      id="fc_385337430"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:CapitalizedComputerSoftwareNet
      contextRef="cref_685214448"
      id="fc_1587703474"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="cref_161598891"
      id="fc_416412097"
      unitRef="uref_917344505"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="cref_1629343917"
      id="fc_610526294"
      unitRef="uref_917344505"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="cref_161047949"
      id="fc_1589776452"
      unitRef="uref_917344505"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="cref_602010912"
      id="fc_602010912"
      unitRef="uref_917344505"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="cref_602010912"
      id="fc_381563882"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="cref_1629343917"
      id="fc_593352664"
      unitRef="uref_917344505"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="cref_1012969921"
      id="fc_1732690992"
      unitRef="uref_917344505"
      xsi:nil="true"/>
    <mrai:StockIssuedDuringPeriodValueIssuedForService
      contextRef="cref_1012969921"
      id="fc_1681314831"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <mrai:StockIssuedDuringPeriodValueIssuedForService
      contextRef="cref_717232960"
      id="fc_1663925024"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <mrai:StockIssuedDuringPeriodValueIssuedForService
      contextRef="cref_1681429834"
      id="fc_1796030402"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="cref_1629343917"
      id="fc_1873709855"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="cref_837610684"
      id="fc_1915327799"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="cref_2104063504"
      id="fc_542082736"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="cref_1629343917"
      id="fc_1974127053"
      unitRef="uref_917344505"
      xsi:nil="true"/>
    <mrai:StockIssuedDuringPeriodValueNewIssue
      contextRef="cref_1629343917"
      id="fc_2103500986"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <mrai:StockIssuedDuringPeriodValueNewIssue
      contextRef="cref_1373149467"
      id="fc_271658173"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="cref_1160633274"
      id="fc_1417913060"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="cref_1731395949"
      id="fc_1058965112"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="cref_1713304212"
      id="fc_698654973"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="cref_1160633274"
      id="fc_343830041"
      unitRef="uref_917344505"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="cref_1160633274"
      id="fc_208303367"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="cref_1130559254"
      id="fc_647553196"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="cref_1713304212"
      id="fc_784765201"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="cref_161598891"
      id="fc_1256634727"
      unitRef="uref_917344505"
      xsi:nil="true"/>
    <mrai:StockIssuedDuringPeriodValueIssuedForService
      contextRef="cref_161598891"
      id="fc_960458512"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <mrai:StockIssuedDuringPeriodValueIssuedForService
      contextRef="cref_984413423"
      id="fc_321038621"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <mrai:StockIssuedDuringPeriodValueIssuedForService
      contextRef="cref_223431024"
      id="fc_132650218"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="cref_1160633274"
      id="fc_1879879051"
      unitRef="uref_917344505"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="cref_161047949"
      id="fc_1182582671"
      unitRef="uref_917344505"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="cref_161047949"
      id="fc_2115881254"
      unitRef="uref_388777331"
      xsi:nil="true"/>
    <dei:EntityCentralIndexKey contextRef="cref_678316177" id="ixv-5881">0001844392</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="cref_678316177" id="ixv-5882">false</dei:AmendmentFlag>
    <dei:DocumentFiscalPeriodFocus contextRef="cref_678316177" id="ixv-5883">Q2</dei:DocumentFiscalPeriodFocus>
    <dei:CurrentFiscalYearEndDate contextRef="cref_678316177" id="ixv-5884">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentType contextRef="cref_678316177" id="ixv-7108">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport contextRef="cref_678316177" id="ixv-7109">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate contextRef="cref_678316177" id="ixv-7110">2026-06-30</dei:DocumentPeriodEndDate>
    <dei:DocumentFiscalYearFocus contextRef="cref_678316177" id="ixv-7111">2026</dei:DocumentFiscalYearFocus>
    <dei:DocumentTransitionReport contextRef="cref_678316177" id="ixv-7112">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="cref_678316177" id="ixv-7113">001-40904</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="cref_678316177" id="ixv-7114">MARPAI, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="cref_678316177" id="ixv-7115">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="cref_678316177" id="ixv-7116">86-1916231</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="cref_678316177" id="ixv-7117">615 Channelside Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="cref_678316177" id="ixv-7118">Suite 207</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="cref_678316177" id="ixv-7119">Tampa</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="cref_678316177" id="ixv-7120">FL</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="cref_678316177" id="ixv-7121">33602</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="cref_678316177" id="ixv-7122">(855)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="cref_678316177" id="ixv-7123">389-7330</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="cref_678316177" id="ixv-7124">Class A Common Stock, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="cref_678316177" id="ixv-7125">MRAI</dei:TradingSymbol>
    <dei:EntityCurrentReportingStatus contextRef="cref_678316177" id="ixv-7126">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="cref_678316177" id="ixv-7127">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="cref_678316177" id="ixv-7128">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="cref_678316177" id="ixv-7129">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="cref_678316177" id="ixv-7130">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="cref_678316177" id="ixv-7131">false</dei:EntityExTransitionPeriod>
    <dei:EntityShellCompany contextRef="cref_678316177" id="ixv-7132">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="cref_16326568"
      decimals="INF"
      id="ixv-7133"
      unitRef="uref_917344505">26829834</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="cref_685214448"
      decimals="-3"
      id="ixv-7134"
      unitRef="uref_388777331">138000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="cref_560512737"
      decimals="-3"
      id="ixv-7135"
      unitRef="uref_388777331">133000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashCurrent
      contextRef="cref_685214448"
      decimals="-3"
      id="ixv-7136"
      unitRef="uref_388777331">6437000</us-gaap:RestrictedCashCurrent>
    <us-gaap:RestrictedCashCurrent
      contextRef="cref_560512737"
      decimals="-3"
      id="ixv-7137"
      unitRef="uref_388777331">8818000</us-gaap:RestrictedCashCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="cref_685214448"
      decimals="-3"
      id="ixv-7138"
      unitRef="uref_388777331">86000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="cref_560512737"
      decimals="-3"
      id="ixv-7139"
      unitRef="uref_388777331">21000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="cref_685214448"
      decimals="-3"
      id="ixv-7140"
      unitRef="uref_388777331">1017000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="cref_560512737"
      decimals="-3"
      id="ixv-7141"
      unitRef="uref_388777331">697000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:UnbilledReceivablesCurrent
      contextRef="cref_685214448"
      decimals="-3"
      id="ixv-7142"
      unitRef="uref_388777331">1085000</us-gaap:UnbilledReceivablesCurrent>
    <us-gaap:UnbilledReceivablesCurrent
      contextRef="cref_560512737"
      decimals="-3"
      id="ixv-7143"
      unitRef="uref_388777331">280000</us-gaap:UnbilledReceivablesCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="cref_685214448"
      decimals="-3"
      id="ixv-7144"
      unitRef="uref_388777331">327000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="cref_560512737"
      decimals="-3"
      id="ixv-7145"
      unitRef="uref_388777331">408000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="cref_685214448"
      decimals="-3"
      id="ixv-7146"
      unitRef="uref_388777331">9004000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="cref_560512737"
      decimals="-3"
      id="ixv-7147"
      unitRef="uref_388777331">10336000</us-gaap:AssetsCurrent>
    <us-gaap:CapitalizedComputerSoftwareNet
      contextRef="cref_560512737"
      decimals="-3"
      id="ixv-7148"
      unitRef="uref_388777331">60000</us-gaap:CapitalizedComputerSoftwareNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="cref_685214448"
      decimals="-3"
      id="ixv-7149"
      unitRef="uref_388777331">193000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="cref_560512737"
      decimals="-3"
      id="ixv-7150"
      unitRef="uref_388777331">218000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:DepositsAssetsNoncurrent
      contextRef="cref_685214448"
      decimals="-3"
      id="ixv-7151"
      unitRef="uref_388777331">227000</us-gaap:DepositsAssetsNoncurrent>
    <us-gaap:DepositsAssetsNoncurrent
      contextRef="cref_560512737"
      decimals="-3"
      id="ixv-7152"
      unitRef="uref_388777331">229000</us-gaap:DepositsAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="cref_685214448"
      decimals="-3"
      id="ixv-7153"
      unitRef="uref_388777331">43000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="cref_560512737"
      decimals="-3"
      id="ixv-7154"
      unitRef="uref_388777331">61000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="cref_685214448"
      decimals="-3"
      id="ixv-7155"
      unitRef="uref_388777331">9467000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="cref_560512737"
      decimals="-3"
      id="ixv-7156"
      unitRef="uref_388777331">10904000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="cref_685214448"
      decimals="-3"
      id="ixv-7157"
      unitRef="uref_388777331">5783000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="cref_560512737"
      decimals="-3"
      id="ixv-7158"
      unitRef="uref_388777331">3668000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="cref_685214448"
      decimals="-3"
      id="ixv-7159"
      unitRef="uref_388777331">2456000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="cref_560512737"
      decimals="-3"
      id="ixv-7160"
      unitRef="uref_388777331">2115000</us-gaap:AccruedLiabilitiesCurrent>
    <mrai:AccruedFiduciaryObligationsCurrent
      contextRef="cref_685214448"
      decimals="-3"
      id="ixv-7161"
      unitRef="uref_388777331">7270000</mrai:AccruedFiduciaryObligationsCurrent>
    <mrai:AccruedFiduciaryObligationsCurrent
      contextRef="cref_560512737"
      decimals="-3"
      id="ixv-7162"
      unitRef="uref_388777331">8521000</mrai:AccruedFiduciaryObligationsCurrent>
    <us-gaap:DeferredRevenueCurrent
      contextRef="cref_685214448"
      decimals="-3"
      id="ixv-7163"
      unitRef="uref_388777331">317000</us-gaap:DeferredRevenueCurrent>
    <us-gaap:DeferredRevenueCurrent
      contextRef="cref_560512737"
      decimals="-3"
      id="ixv-7164"
      unitRef="uref_388777331">0</us-gaap:DeferredRevenueCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="cref_685214448"
      decimals="-3"
      id="ixv-7165"
      unitRef="uref_388777331">317000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="cref_560512737"
      decimals="-3"
      id="ixv-7166"
      unitRef="uref_388777331">89000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="cref_685214448"
      decimals="-3"
      id="ixv-7167"
      unitRef="uref_388777331">278000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="cref_560512737"
      decimals="-3"
      id="ixv-7168"
      unitRef="uref_388777331">264000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:ConvertibleDebtCurrent
      contextRef="cref_685214448"
      decimals="-3"
      id="ixv-7169"
      unitRef="uref_388777331">1966000</us-gaap:ConvertibleDebtCurrent>
    <us-gaap:ConvertibleDebtCurrent
      contextRef="cref_560512737"
      decimals="-3"
      id="ixv-7170"
      unitRef="uref_388777331">3037000</us-gaap:ConvertibleDebtCurrent>
    <mrai:OtherShorttermLiabilities
      contextRef="cref_685214448"
      decimals="-3"
      id="ixv-7171"
      unitRef="uref_388777331">2450000</mrai:OtherShorttermLiabilities>
    <mrai:OtherShorttermLiabilities
      contextRef="cref_560512737"
      decimals="-3"
      id="ixv-7172"
      unitRef="uref_388777331">8000000</mrai:OtherShorttermLiabilities>
    <mrai:VendorFinancingAdvance
      contextRef="cref_685214448"
      decimals="-3"
      id="ixv-7173"
      unitRef="uref_388777331">2000000</mrai:VendorFinancingAdvance>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="cref_2053830456"
      decimals="-3"
      id="ixv-7174"
      unitRef="uref_388777331">1026000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="cref_685214448"
      decimals="-3"
      id="ixv-7175"
      unitRef="uref_388777331">23546000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="cref_560512737"
      decimals="-3"
      id="ixv-7176"
      unitRef="uref_388777331">25694000</us-gaap:LiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="cref_685214448"
      decimals="-3"
      id="ixv-7177"
      unitRef="uref_388777331">18306000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="cref_560512737"
      decimals="-3"
      id="ixv-7178"
      unitRef="uref_388777331">11450000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:ConvertibleDebtNoncurrent
      contextRef="cref_685214448"
      decimals="-3"
      id="ixv-7179"
      unitRef="uref_388777331">6122000</us-gaap:ConvertibleDebtNoncurrent>
    <us-gaap:ConvertibleDebtNoncurrent
      contextRef="cref_560512737"
      decimals="-3"
      id="ixv-7180"
      unitRef="uref_388777331">5795000</us-gaap:ConvertibleDebtNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="cref_685214448"
      decimals="-3"
      id="ixv-7181"
      unitRef="uref_388777331">384000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="cref_560512737"
      decimals="-3"
      id="ixv-7182"
      unitRef="uref_388777331">528000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:Liabilities
      contextRef="cref_685214448"
      decimals="-3"
      id="ixv-7183"
      unitRef="uref_388777331">48358000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="cref_560512737"
      decimals="-3"
      id="ixv-7184"
      unitRef="uref_388777331">43467000</us-gaap:Liabilities>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="cref_685214448"
      decimals="4"
      id="ixv-7185"
      unitRef="uref_1972424199">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="cref_560512737"
      decimals="4"
      id="ixv-7186"
      unitRef="uref_1972424199">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="cref_685214448"
      decimals="INF"
      id="ixv-7187"
      unitRef="uref_917344505">2000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="cref_560512737"
      decimals="INF"
      id="ixv-7188"
      unitRef="uref_917344505">2000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="cref_685214448"
      decimals="INF"
      id="ixv-7189"
      unitRef="uref_917344505">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="cref_560512737"
      decimals="INF"
      id="ixv-7190"
      unitRef="uref_917344505">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="cref_685214448"
      decimals="INF"
      id="ixv-7191"
      unitRef="uref_917344505">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="cref_560512737"
      decimals="INF"
      id="ixv-7192"
      unitRef="uref_917344505">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="cref_685214448"
      decimals="4"
      id="ixv-7193"
      unitRef="uref_1972424199">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="cref_560512737"
      decimals="4"
      id="ixv-7194"
      unitRef="uref_1972424199">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="cref_685214448"
      decimals="INF"
      id="ixv-7195"
      unitRef="uref_917344505">227791050</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="cref_560512737"
      decimals="INF"
      id="ixv-7196"
      unitRef="uref_917344505">227791050</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="cref_685214448"
      decimals="INF"
      id="ixv-7197"
      unitRef="uref_917344505">26667334</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="cref_685214448"
      decimals="INF"
      id="ixv-7198"
      unitRef="uref_917344505">26667334</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="cref_560512737"
      decimals="INF"
      id="ixv-7199"
      unitRef="uref_917344505">24035610</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="cref_560512737"
      decimals="INF"
      id="ixv-7200"
      unitRef="uref_917344505">24035610</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="cref_685214448"
      decimals="-3"
      id="ixv-7201"
      unitRef="uref_388777331">3000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="cref_560512737"
      decimals="-3"
      id="ixv-7202"
      unitRef="uref_388777331">2000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="cref_685214448"
      decimals="-3"
      id="ixv-7203"
      unitRef="uref_388777331">84266000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="cref_560512737"
      decimals="-3"
      id="ixv-7204"
      unitRef="uref_388777331">82829000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="cref_685214448"
      decimals="-3"
      id="ixv-7205"
      unitRef="uref_388777331">-123160000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="cref_560512737"
      decimals="-3"
      id="ixv-7206"
      unitRef="uref_388777331">-115394000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="cref_685214448"
      decimals="-3"
      id="ixv-7207"
      unitRef="uref_388777331">-38891000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="cref_560512737"
      decimals="-3"
      id="ixv-7208"
      unitRef="uref_388777331">-32563000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="cref_685214448"
      decimals="-3"
      id="ixv-7209"
      unitRef="uref_388777331">9467000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="cref_560512737"
      decimals="-3"
      id="ixv-7210"
      unitRef="uref_388777331">10904000</us-gaap:LiabilitiesAndStockholdersEquity>
    <mrai:RevenueRelatedParty
      contextRef="cref_1864859878"
      decimals="-3"
      id="ixv-7211"
      unitRef="uref_388777331">183000</mrai:RevenueRelatedParty>
    <mrai:RevenueRelatedParty
      contextRef="cref_696692331"
      decimals="-3"
      id="ixv-7212"
      unitRef="uref_388777331">0</mrai:RevenueRelatedParty>
    <mrai:RevenueRelatedParty
      contextRef="cref_678316177"
      decimals="-3"
      id="ixv-7213"
      unitRef="uref_388777331">183000</mrai:RevenueRelatedParty>
    <mrai:RevenueRelatedParty
      contextRef="cref_968639710"
      decimals="-3"
      id="ixv-7214"
      unitRef="uref_388777331">0</mrai:RevenueRelatedParty>
    <us-gaap:Revenues
      contextRef="cref_1864859878"
      decimals="-3"
      id="ixv-7215"
      unitRef="uref_388777331">4166000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="cref_696692331"
      decimals="-3"
      id="ixv-7216"
      unitRef="uref_388777331">4656000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="cref_678316177"
      decimals="-3"
      id="ixv-7217"
      unitRef="uref_388777331">8610000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="cref_968639710"
      decimals="-3"
      id="ixv-7218"
      unitRef="uref_388777331">10074000</us-gaap:Revenues>
    <us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
      contextRef="cref_1864859878"
      decimals="-3"
      id="ixv-7219"
      unitRef="uref_388777331">3169000</us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization>
    <us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
      contextRef="cref_696692331"
      decimals="-3"
      id="ixv-7220"
      unitRef="uref_388777331">3910000</us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization>
    <us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
      contextRef="cref_678316177"
      decimals="-3"
      id="ixv-7221"
      unitRef="uref_388777331">6408000</us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization>
    <us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
      contextRef="cref_968639710"
      decimals="-3"
      id="ixv-7222"
      unitRef="uref_388777331">7395000</us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="cref_1864859878"
      decimals="-3"
      id="ixv-7223"
      unitRef="uref_388777331">3069000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="cref_696692331"
      decimals="-3"
      id="ixv-7224"
      unitRef="uref_388777331">2483000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="cref_678316177"
      decimals="-3"
      id="ixv-7225"
      unitRef="uref_388777331">5199000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="cref_968639710"
      decimals="-3"
      id="ixv-7226"
      unitRef="uref_388777331">4766000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:InformationTechnologyAndDataProcessing
      contextRef="cref_1864859878"
      decimals="-3"
      id="ixv-7227"
      unitRef="uref_388777331">1109000</us-gaap:InformationTechnologyAndDataProcessing>
    <us-gaap:InformationTechnologyAndDataProcessing
      contextRef="cref_696692331"
      decimals="-3"
      id="ixv-7228"
      unitRef="uref_388777331">1291000</us-gaap:InformationTechnologyAndDataProcessing>
    <us-gaap:InformationTechnologyAndDataProcessing
      contextRef="cref_678316177"
      decimals="-3"
      id="ixv-7229"
      unitRef="uref_388777331">2266000</us-gaap:InformationTechnologyAndDataProcessing>
    <us-gaap:InformationTechnologyAndDataProcessing
      contextRef="cref_968639710"
      decimals="-3"
      id="ixv-7230"
      unitRef="uref_388777331">2681000</us-gaap:InformationTechnologyAndDataProcessing>
    <us-gaap:SellingAndMarketingExpense
      contextRef="cref_1864859878"
      decimals="-3"
      id="ixv-7231"
      unitRef="uref_388777331">136000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="cref_696692331"
      decimals="-3"
      id="ixv-7232"
      unitRef="uref_388777331">312000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="cref_678316177"
      decimals="-3"
      id="fc_2063777108"
      unitRef="uref_388777331">365000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="cref_968639710"
      decimals="-3"
      id="fc_1945895605"
      unitRef="uref_388777331">556000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="cref_968639710"
      decimals="-3"
      id="ixv-7235"
      unitRef="uref_388777331">7000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:DepreciationAndAmortization
      contextRef="cref_696692331"
      decimals="-3"
      id="ixv-7236"
      unitRef="uref_388777331">107000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="cref_678316177"
      decimals="-3"
      id="ixv-7237"
      unitRef="uref_388777331">60000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="cref_968639710"
      decimals="-3"
      id="ixv-7238"
      unitRef="uref_388777331">214000</us-gaap:DepreciationAndAmortization>
    <mrai:FacilitiesExpense
      contextRef="cref_1864859878"
      decimals="-3"
      id="ixv-7239"
      unitRef="uref_388777331">116000</mrai:FacilitiesExpense>
    <mrai:FacilitiesExpense
      contextRef="cref_696692331"
      decimals="-3"
      id="ixv-7240"
      unitRef="uref_388777331">160000</mrai:FacilitiesExpense>
    <mrai:FacilitiesExpense
      contextRef="cref_678316177"
      decimals="-3"
      id="ixv-7241"
      unitRef="uref_388777331">229000</mrai:FacilitiesExpense>
    <mrai:FacilitiesExpense
      contextRef="cref_968639710"
      decimals="-3"
      id="ixv-7242"
      unitRef="uref_388777331">311000</mrai:FacilitiesExpense>
    <us-gaap:CostsAndExpenses
      contextRef="cref_1864859878"
      decimals="-3"
      id="ixv-7243"
      unitRef="uref_388777331">7599000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="cref_696692331"
      decimals="-3"
      id="ixv-7244"
      unitRef="uref_388777331">8263000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="cref_678316177"
      decimals="-3"
      id="ixv-7245"
      unitRef="uref_388777331">14527000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="cref_968639710"
      decimals="-3"
      id="ixv-7246"
      unitRef="uref_388777331">15930000</us-gaap:CostsAndExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="cref_1864859878"
      decimals="-3"
      id="ixv-7247"
      unitRef="uref_388777331">-3433000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="cref_696692331"
      decimals="-3"
      id="ixv-7248"
      unitRef="uref_388777331">-3607000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="cref_678316177"
      decimals="-3"
      id="ixv-7249"
      unitRef="uref_388777331">-5917000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="cref_968639710"
      decimals="-3"
      id="ixv-7250"
      unitRef="uref_388777331">-5856000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OtherNonoperatingIncome
      contextRef="cref_1864859878"
      decimals="-3"
      id="ixv-7251"
      unitRef="uref_388777331">77000</us-gaap:OtherNonoperatingIncome>
    <us-gaap:OtherNonoperatingIncome
      contextRef="cref_696692331"
      decimals="-3"
      id="ixv-7252"
      unitRef="uref_388777331">49000</us-gaap:OtherNonoperatingIncome>
    <us-gaap:OtherNonoperatingIncome
      contextRef="cref_678316177"
      decimals="-3"
      id="ixv-7253"
      unitRef="uref_388777331">153000</us-gaap:OtherNonoperatingIncome>
    <us-gaap:OtherNonoperatingIncome
      contextRef="cref_968639710"
      decimals="-3"
      id="ixv-7254"
      unitRef="uref_388777331">49000</us-gaap:OtherNonoperatingIncome>
    <us-gaap:InterestExpenseNonoperating
      contextRef="cref_1864859878"
      decimals="-3"
      id="ixv-7255"
      unitRef="uref_388777331">1227000</us-gaap:InterestExpenseNonoperating>
    <us-gaap:InterestExpenseNonoperating
      contextRef="cref_696692331"
      decimals="-3"
      id="ixv-7256"
      unitRef="uref_388777331">813000</us-gaap:InterestExpenseNonoperating>
    <us-gaap:InterestExpenseNonoperating
      contextRef="cref_678316177"
      decimals="-3"
      id="ixv-7257"
      unitRef="uref_388777331">2002000</us-gaap:InterestExpenseNonoperating>
    <us-gaap:InterestExpenseNonoperating
      contextRef="cref_968639710"
      decimals="-3"
      id="ixv-7258"
      unitRef="uref_388777331">1633000</us-gaap:InterestExpenseNonoperating>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="cref_1864859878"
      decimals="-3"
      id="ixv-7259"
      unitRef="uref_388777331">-4583000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="cref_696692331"
      decimals="-3"
      id="ixv-7260"
      unitRef="uref_388777331">-4371000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="cref_678316177"
      decimals="-3"
      id="ixv-7261"
      unitRef="uref_388777331">-7766000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="cref_968639710"
      decimals="-3"
      id="ixv-7262"
      unitRef="uref_388777331">-7440000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="cref_1864859878"
      decimals="-3"
      id="ixv-7263"
      unitRef="uref_388777331">-4583000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="cref_696692331"
      decimals="-3"
      id="ixv-7264"
      unitRef="uref_388777331">-4371000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="cref_678316177"
      decimals="-3"
      id="ixv-7265"
      unitRef="uref_388777331">-7766000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="cref_968639710"
      decimals="-3"
      id="ixv-7266"
      unitRef="uref_388777331">-7440000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareDiluted
      contextRef="cref_1864859878"
      decimals="2"
      id="ixv-7267"
      unitRef="uref_1972424199">-0.18</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="cref_1864859878"
      decimals="2"
      id="ixv-7268"
      unitRef="uref_1972424199">-0.18</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="cref_696692331"
      decimals="2"
      id="ixv-7269"
      unitRef="uref_1972424199">-0.28</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="cref_696692331"
      decimals="2"
      id="ixv-7270"
      unitRef="uref_1972424199">-0.28</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="cref_678316177"
      decimals="2"
      id="ixv-7271"
      unitRef="uref_1972424199">-0.31</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="cref_678316177"
      decimals="2"
      id="ixv-7272"
      unitRef="uref_1972424199">-0.31</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="cref_968639710"
      decimals="2"
      id="ixv-7273"
      unitRef="uref_1972424199">-0.49</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="cref_968639710"
      decimals="2"
      id="ixv-7274"
      unitRef="uref_1972424199">-0.49</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="cref_1864859878"
      decimals="INF"
      id="ixv-7275"
      unitRef="uref_917344505">25860374</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="cref_1864859878"
      decimals="INF"
      id="ixv-7276"
      unitRef="uref_917344505">25860374</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="cref_696692331"
      decimals="INF"
      id="ixv-7277"
      unitRef="uref_917344505">15503132</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="cref_696692331"
      decimals="INF"
      id="ixv-7278"
      unitRef="uref_917344505">15503132</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="cref_678316177"
      decimals="0"
      id="ixv-7279"
      unitRef="uref_917344505">25277172</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="cref_678316177"
      decimals="0"
      id="ixv-7280"
      unitRef="uref_917344505">25277172</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="cref_968639710"
      decimals="0"
      id="ixv-7281"
      unitRef="uref_917344505">15140332</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="cref_968639710"
      decimals="0"
      id="ixv-7282"
      unitRef="uref_917344505">15140332</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="cref_1103525179"
      decimals="0"
      id="ixv-7283"
      unitRef="uref_917344505">25292667</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="cref_1103525179"
      decimals="-3"
      id="ixv-7284"
      unitRef="uref_388777331">3000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="cref_322972255"
      decimals="-3"
      id="ixv-7285"
      unitRef="uref_388777331">83329000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="cref_1529656207"
      decimals="-3"
      id="ixv-7286"
      unitRef="uref_388777331">-118577000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="cref_94868961"
      decimals="-3"
      id="ixv-7287"
      unitRef="uref_388777331">-35245000</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="cref_1715742340"
      decimals="-3"
      id="ixv-7288"
      unitRef="uref_388777331">917000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="cref_1864859878"
      decimals="-3"
      id="ixv-7289"
      unitRef="uref_388777331">917000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="cref_984413423"
      decimals="INF"
      id="ixv-7290"
      unitRef="uref_917344505">1329667</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="cref_984413423"
      decimals="0"
      id="ixv-7291"
      unitRef="uref_917344505">45000</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <mrai:StockIssuedDuringPeriodValueIssuedForService
      contextRef="cref_1715742340"
      decimals="-3"
      id="ixv-7292"
      unitRef="uref_388777331">20000</mrai:StockIssuedDuringPeriodValueIssuedForService>
    <mrai:StockIssuedDuringPeriodValueIssuedForService
      contextRef="cref_1864859878"
      decimals="-3"
      id="ixv-7293"
      unitRef="uref_388777331">20000</mrai:StockIssuedDuringPeriodValueIssuedForService>
    <us-gaap:NetIncomeLoss
      contextRef="cref_223431024"
      decimals="-3"
      id="ixv-7294"
      unitRef="uref_388777331">-4583000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="cref_1864859878"
      decimals="-3"
      id="ixv-7295"
      unitRef="uref_388777331">-4583000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="cref_1215524900"
      decimals="INF"
      id="ixv-7296"
      unitRef="uref_917344505">26667334</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="cref_1215524900"
      decimals="-3"
      id="ixv-7297"
      unitRef="uref_388777331">3000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="cref_833101924"
      decimals="-3"
      id="ixv-7298"
      unitRef="uref_388777331">84266000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="cref_94573302"
      decimals="-3"
      id="ixv-7299"
      unitRef="uref_388777331">-123160000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="cref_685214448"
      decimals="-3"
      id="ixv-7300"
      unitRef="uref_388777331">-38891000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="cref_1824153813"
      decimals="0"
      id="ixv-7301"
      unitRef="uref_917344505">14896686</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="cref_1824153813"
      decimals="-3"
      id="ixv-7302"
      unitRef="uref_388777331">1000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="cref_1228721679"
      decimals="-3"
      id="ixv-7303"
      unitRef="uref_388777331">71698000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="cref_659268312"
      decimals="-3"
      id="ixv-7304"
      unitRef="uref_388777331">-101903000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="cref_1226747563"
      decimals="-3"
      id="ixv-7305"
      unitRef="uref_388777331">-30204000</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="cref_2104063504"
      decimals="-3"
      id="ixv-7306"
      unitRef="uref_388777331">469000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="cref_696692331"
      decimals="-3"
      id="ixv-7307"
      unitRef="uref_388777331">469000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="cref_837610684"
      decimals="INF"
      id="ixv-7308"
      unitRef="uref_917344505">184500</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="cref_837610684"
      decimals="INF"
      id="ixv-7309"
      unitRef="uref_917344505">725000</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <mrai:StockIssuedDuringPeriodValueIssuedForService
      contextRef="cref_2104063504"
      decimals="-3"
      id="ixv-7310"
      unitRef="uref_388777331">1008000</mrai:StockIssuedDuringPeriodValueIssuedForService>
    <mrai:StockIssuedDuringPeriodValueIssuedForService
      contextRef="cref_696692331"
      decimals="-3"
      id="ixv-7311"
      unitRef="uref_388777331">1008000</mrai:StockIssuedDuringPeriodValueIssuedForService>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="cref_837610684"
      decimals="0"
      id="ixv-7312"
      unitRef="uref_917344505">730000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <mrai:StockIssuedDuringPeriodValueNewIssue
      contextRef="cref_837610684"
      decimals="-3"
      id="ixv-7313"
      unitRef="uref_388777331">1000</mrai:StockIssuedDuringPeriodValueNewIssue>
    <mrai:StockIssuedDuringPeriodValueNewIssue
      contextRef="cref_2104063504"
      decimals="-3"
      id="ixv-7314"
      unitRef="uref_388777331">730000</mrai:StockIssuedDuringPeriodValueNewIssue>
    <mrai:StockIssuedDuringPeriodValueNewIssue
      contextRef="cref_696692331"
      decimals="-3"
      id="ixv-7315"
      unitRef="uref_388777331">731000</mrai:StockIssuedDuringPeriodValueNewIssue>
    <us-gaap:NetIncomeLoss
      contextRef="cref_1373149467"
      decimals="-3"
      id="ixv-7316"
      unitRef="uref_388777331">-4371000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="cref_696692331"
      decimals="-3"
      id="ixv-7317"
      unitRef="uref_388777331">-4371000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="cref_279763595"
      decimals="INF"
      id="ixv-7318"
      unitRef="uref_917344505">16536186</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="cref_279763595"
      decimals="-3"
      id="ixv-7319"
      unitRef="uref_388777331">2000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="cref_1672293235"
      decimals="-3"
      id="ixv-7320"
      unitRef="uref_388777331">73905000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="cref_1330789163"
      decimals="-3"
      id="ixv-7321"
      unitRef="uref_388777331">-106274000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="cref_156869995"
      decimals="-3"
      id="ixv-7322"
      unitRef="uref_388777331">-32367000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="cref_967157915"
      decimals="INF"
      id="ixv-7323"
      unitRef="uref_917344505">24035610</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="cref_967157915"
      decimals="-3"
      id="ixv-7324"
      unitRef="uref_388777331">2000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="cref_385193611"
      decimals="-3"
      id="ixv-7325"
      unitRef="uref_388777331">82829000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="cref_1659572957"
      decimals="-3"
      id="ixv-7326"
      unitRef="uref_388777331">-115394000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="cref_560512737"
      decimals="-3"
      id="ixv-7327"
      unitRef="uref_388777331">-32563000</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="cref_1130559254"
      decimals="-3"
      id="ixv-7328"
      unitRef="uref_388777331">1331000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="cref_678316177"
      decimals="-3"
      id="ixv-7329"
      unitRef="uref_388777331">1331000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="cref_1731395949"
      decimals="0"
      id="ixv-7330"
      unitRef="uref_917344505">2386966</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="cref_1731395949"
      decimals="-3"
      id="ixv-7331"
      unitRef="uref_388777331">1000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="cref_678316177"
      decimals="-3"
      id="ixv-7332"
      unitRef="uref_388777331">1000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="cref_1731395949"
      decimals="0"
      id="ixv-7333"
      unitRef="uref_917344505">103091</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <mrai:StockIssuedDuringPeriodValueIssuedForService
      contextRef="cref_1130559254"
      decimals="-3"
      id="ixv-7334"
      unitRef="uref_388777331">55000</mrai:StockIssuedDuringPeriodValueIssuedForService>
    <mrai:StockIssuedDuringPeriodValueIssuedForService
      contextRef="cref_678316177"
      decimals="-3"
      id="ixv-7335"
      unitRef="uref_388777331">55000</mrai:StockIssuedDuringPeriodValueIssuedForService>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="cref_1731395949"
      decimals="INF"
      id="ixv-7336"
      unitRef="uref_917344505">141667</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="cref_1130559254"
      decimals="-3"
      id="ixv-7337"
      unitRef="uref_388777331">51000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="cref_678316177"
      decimals="-3"
      id="ixv-7338"
      unitRef="uref_388777331">51000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:NetIncomeLoss
      contextRef="cref_1713304212"
      decimals="-3"
      id="ixv-7339"
      unitRef="uref_388777331">-7766000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="cref_678316177"
      decimals="-3"
      id="ixv-7340"
      unitRef="uref_388777331">-7766000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="cref_1215524900"
      decimals="0"
      id="ixv-7341"
      unitRef="uref_917344505">26667334</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="cref_1215524900"
      decimals="-3"
      id="ixv-7342"
      unitRef="uref_388777331">3000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="cref_833101924"
      decimals="-3"
      id="ixv-7343"
      unitRef="uref_388777331">84266000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="cref_94573302"
      decimals="-3"
      id="ixv-7344"
      unitRef="uref_388777331">-123160000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="cref_685214448"
      decimals="-3"
      id="ixv-7345"
      unitRef="uref_388777331">-38891000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="cref_815244211"
      decimals="INF"
      id="fc_557180224"
      unitRef="uref_917344505">14237176</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="cref_815244211"
      decimals="-3"
      id="ixv-7347"
      unitRef="uref_388777331">1000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="cref_1318945957"
      decimals="-3"
      id="ixv-7348"
      unitRef="uref_388777331">71124000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="cref_1489525931"
      decimals="-3"
      id="ixv-7349"
      unitRef="uref_388777331">-98834000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="cref_1534084021"
      decimals="-3"
      id="ixv-7350"
      unitRef="uref_388777331">-27709000</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="cref_656402117"
      decimals="-3"
      id="ixv-7351"
      unitRef="uref_388777331">1043000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="cref_968639710"
      decimals="-3"
      id="ixv-7352"
      unitRef="uref_388777331">1043000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="cref_717232960"
      decimals="0"
      id="ixv-7353"
      unitRef="uref_917344505">844010</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="cref_717232960"
      decimals="0"
      id="ixv-7354"
      unitRef="uref_917344505">725000</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <mrai:StockIssuedDuringPeriodValueIssuedForService
      contextRef="cref_656402117"
      decimals="-3"
      id="ixv-7355"
      unitRef="uref_388777331">1008000</mrai:StockIssuedDuringPeriodValueIssuedForService>
    <mrai:StockIssuedDuringPeriodValueIssuedForService
      contextRef="cref_968639710"
      decimals="-3"
      id="ixv-7356"
      unitRef="uref_388777331">1008000</mrai:StockIssuedDuringPeriodValueIssuedForService>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="cref_717232960"
      decimals="0"
      id="ixv-7357"
      unitRef="uref_917344505">730000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <mrai:StockIssuedDuringPeriodValueNewIssue
      contextRef="cref_717232960"
      decimals="-3"
      id="fc_1408295362"
      unitRef="uref_388777331">1000</mrai:StockIssuedDuringPeriodValueNewIssue>
    <mrai:StockIssuedDuringPeriodValueNewIssue
      contextRef="cref_656402117"
      decimals="-3"
      id="fc_656402117"
      unitRef="uref_388777331">730000</mrai:StockIssuedDuringPeriodValueNewIssue>
    <mrai:StockIssuedDuringPeriodValueNewIssue
      contextRef="cref_968639710"
      decimals="-3"
      id="ixv-7360"
      unitRef="uref_388777331">731000</mrai:StockIssuedDuringPeriodValueNewIssue>
    <us-gaap:NetIncomeLoss
      contextRef="cref_1681429834"
      decimals="-3"
      id="ixv-7361"
      unitRef="uref_388777331">-7440000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="cref_968639710"
      decimals="-3"
      id="ixv-7362"
      unitRef="uref_388777331">-7440000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="cref_279763595"
      decimals="0"
      id="ixv-7363"
      unitRef="uref_917344505">16536186</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="cref_279763595"
      decimals="-3"
      id="ixv-7364"
      unitRef="uref_388777331">2000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="cref_1672293235"
      decimals="-3"
      id="ixv-7365"
      unitRef="uref_388777331">73905000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="cref_1330789163"
      decimals="-3"
      id="ixv-7366"
      unitRef="uref_388777331">-106274000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="cref_156869995"
      decimals="-3"
      id="ixv-7367"
      unitRef="uref_388777331">-32367000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="cref_678316177"
      decimals="-3"
      id="ixv-7368"
      unitRef="uref_388777331">-7766000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="cref_968639710"
      decimals="-3"
      id="ixv-7369"
      unitRef="uref_388777331">-7440000</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationAndAmortization
      contextRef="cref_678316177"
      decimals="-3"
      id="ixv-7370"
      unitRef="uref_388777331">60000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="cref_968639710"
      decimals="-3"
      id="ixv-7371"
      unitRef="uref_388777331">214000</us-gaap:DepreciationAndAmortization>
    <us-gaap:ShareBasedCompensation
      contextRef="cref_678316177"
      decimals="-3"
      id="ixv-7372"
      unitRef="uref_388777331">1120000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="cref_968639710"
      decimals="-3"
      id="ixv-7373"
      unitRef="uref_388777331">1043000</us-gaap:ShareBasedCompensation>
    <us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims
      contextRef="cref_678316177"
      decimals="-3"
      id="ixv-7374"
      unitRef="uref_388777331">55000</us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims>
    <us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims
      contextRef="cref_968639710"
      decimals="-3"
      id="ixv-7375"
      unitRef="uref_388777331">1008000</us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="cref_678316177"
      decimals="-3"
      id="ixv-7376"
      unitRef="uref_388777331">25000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="cref_968639710"
      decimals="-3"
      id="ixv-7377"
      unitRef="uref_388777331">31000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OtherNoncashExpense
      contextRef="cref_678316177"
      decimals="-3"
      id="ixv-7378"
      unitRef="uref_388777331">1331000</us-gaap:OtherNoncashExpense>
    <us-gaap:OtherNoncashExpense
      contextRef="cref_968639710"
      decimals="-3"
      id="ixv-7379"
      unitRef="uref_388777331">914000</us-gaap:OtherNoncashExpense>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="cref_678316177"
      decimals="-3"
      id="ixv-7380"
      unitRef="uref_388777331">56000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="cref_968639710"
      decimals="-3"
      id="ixv-7381"
      unitRef="uref_388777331">-17000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="cref_678316177"
      decimals="-3"
      id="ixv-7382"
      unitRef="uref_388777331">178000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="cref_678316177"
      decimals="-3"
      id="ixv-7383"
      unitRef="uref_388777331">1303000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="cref_968639710"
      decimals="-3"
      id="ixv-7384"
      unitRef="uref_388777331">56000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="cref_678316177"
      decimals="-3"
      id="ixv-7385"
      unitRef="uref_388777331">-101000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="cref_968639710"
      decimals="-3"
      id="ixv-7386"
      unitRef="uref_388777331">-176000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="cref_678316177"
      decimals="-3"
      id="ixv-7387"
      unitRef="uref_388777331">2115000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="cref_968639710"
      decimals="-3"
      id="ixv-7388"
      unitRef="uref_388777331">479000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="cref_678316177"
      decimals="-3"
      id="ixv-7389"
      unitRef="uref_388777331">604000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="cref_968639710"
      decimals="-3"
      id="ixv-7390"
      unitRef="uref_388777331">-516000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <mrai:IncreaseDecreaseInAccruedFiduciaryObligations
      contextRef="cref_678316177"
      decimals="-3"
      id="ixv-7391"
      unitRef="uref_388777331">-1251000</mrai:IncreaseDecreaseInAccruedFiduciaryObligations>
    <mrai:IncreaseDecreaseInAccruedFiduciaryObligations
      contextRef="cref_968639710"
      decimals="-3"
      id="ixv-7392"
      unitRef="uref_388777331">871000</mrai:IncreaseDecreaseInAccruedFiduciaryObligations>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="cref_678316177"
      decimals="-3"
      id="ixv-7393"
      unitRef="uref_388777331">-130000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="cref_968639710"
      decimals="-3"
      id="ixv-7394"
      unitRef="uref_388777331">-123000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInDueToRelatedParties
      contextRef="cref_678316177"
      decimals="-3"
      id="ixv-7395"
      unitRef="uref_388777331">26000</us-gaap:IncreaseDecreaseInDueToRelatedParties>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="cref_678316177"
      decimals="-3"
      id="fc_834286651"
      unitRef="uref_388777331">203000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="cref_968639710"
      decimals="-3"
      id="fc_669516540"
      unitRef="uref_388777331">92000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="cref_678316177"
      decimals="-3"
      id="ixv-7398"
      unitRef="uref_388777331">-4576000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="cref_968639710"
      decimals="-3"
      id="ixv-7399"
      unitRef="uref_388777331">-3324000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="cref_968639710"
      decimals="-3"
      id="ixv-7400"
      unitRef="uref_388777331">500000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="cref_968639710"
      decimals="-3"
      id="ixv-7401"
      unitRef="uref_388777331">500000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <mrai:ProceedsFromIssuanceOfRelatedPartyPromissoryNotes
      contextRef="cref_678316177"
      decimals="-3"
      id="fc_818846945"
      unitRef="uref_388777331">660000</mrai:ProceedsFromIssuanceOfRelatedPartyPromissoryNotes>
    <us-gaap:RepaymentsOfRelatedPartyDebt
      contextRef="cref_678316177"
      decimals="-3"
      id="ixv-7403"
      unitRef="uref_388777331">660000</us-gaap:RepaymentsOfRelatedPartyDebt>
    <mrai:ProceedsFromVendorFinancingAdvance
      contextRef="cref_678316177"
      decimals="-3"
      id="ixv-7404"
      unitRef="uref_388777331">2000000</mrai:ProceedsFromVendorFinancingAdvance>
    <us-gaap:ProceedsFromRelatedPartyDebt
      contextRef="cref_678316177"
      decimals="-3"
      id="ixv-7405"
      unitRef="uref_388777331">1000000</us-gaap:ProceedsFromRelatedPartyDebt>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="cref_968639710"
      decimals="-3"
      id="ixv-7406"
      unitRef="uref_388777331">3000000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="cref_968639710"
      decimals="-3"
      id="ixv-7407"
      unitRef="uref_388777331">162000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:RepaymentsOfConvertibleDebt
      contextRef="cref_678316177"
      decimals="-3"
      id="ixv-7408"
      unitRef="uref_388777331">800000</us-gaap:RepaymentsOfConvertibleDebt>
    <us-gaap:RepaymentsOfConvertibleDebt
      contextRef="cref_968639710"
      decimals="-3"
      id="ixv-7409"
      unitRef="uref_388777331">1500000</us-gaap:RepaymentsOfConvertibleDebt>
    <mrai:PaymentsToSellerForAcquisition
      contextRef="cref_968639710"
      decimals="-3"
      id="ixv-7410"
      unitRef="uref_388777331">196000</mrai:PaymentsToSellerForAcquisition>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="cref_968639710"
      decimals="-3"
      id="ixv-7411"
      unitRef="uref_388777331">730000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="cref_678316177"
      decimals="-3"
      id="ixv-7412"
      unitRef="uref_388777331">2200000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="cref_968639710"
      decimals="-3"
      id="ixv-7413"
      unitRef="uref_388777331">1872000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="cref_678316177"
      decimals="-3"
      id="ixv-7414"
      unitRef="uref_388777331">-2376000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="cref_968639710"
      decimals="-3"
      id="ixv-7415"
      unitRef="uref_388777331">-952000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="cref_560512737"
      decimals="-3"
      id="ixv-7416"
      unitRef="uref_388777331">8951000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="cref_1534084021"
      decimals="-3"
      id="ixv-7417"
      unitRef="uref_388777331">9232000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="cref_685214448"
      decimals="-3"
      id="ixv-7418"
      unitRef="uref_388777331">6575000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="cref_1226747563"
      decimals="-3"
      id="ixv-7419"
      unitRef="uref_388777331">8280000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="cref_685214448"
      decimals="-3"
      id="ixv-7420"
      unitRef="uref_388777331">138000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="cref_156869995"
      decimals="-3"
      id="ixv-7421"
      unitRef="uref_388777331">619000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashCurrent
      contextRef="cref_685214448"
      decimals="-3"
      id="ixv-7422"
      unitRef="uref_388777331">6437000</us-gaap:RestrictedCashCurrent>
    <us-gaap:RestrictedCashCurrent
      contextRef="cref_156869995"
      decimals="-3"
      id="ixv-7423"
      unitRef="uref_388777331">7661000</us-gaap:RestrictedCashCurrent>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="cref_685214448"
      decimals="-3"
      id="ixv-7424"
      unitRef="uref_388777331">6575000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="cref_156869995"
      decimals="-3"
      id="ixv-7425"
      unitRef="uref_388777331">8280000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet
      contextRef="cref_678316177"
      decimals="-3"
      id="ixv-7426"
      unitRef="uref_388777331">591000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="cref_968639710"
      decimals="-3"
      id="ixv-7427"
      unitRef="uref_388777331">781000</us-gaap:InterestPaidNet>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="cref_678316177" id="ixv-2770">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&lt;span style="font-weight: bold;"&gt;NOTE 1 &#x2013; ORGANIZATION AND DESCRIPTION OF BUSINESS&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;"&gt;Unless the context otherwise requires, throughout, the words &#x201c;Marpai,&#x201d; &#x201c;Marpai, Inc.,&#x201d; &#x201c;we,&#x201d; &#x201c;our,&#x201d; &#x201c;us,&#x201d; the &#x201c;registrant,&#x201d; or the &#x201c;Company&#x201d; refer to Marpai, Inc. and our subsidiaries (as applicable).&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Organization&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;"&gt;Marpai, Inc.&#x2019;s (&#x201c;Marpai&#x201d;, &#x201c;we&#x201d;, or the &#x201c;Company&#x201d;) operations are principally conducted through our wholly owned subsidiaries, Marpai Health, Inc. (&#x201c;Marpai Health&#x201d;), Marpai Administrators LLC (&#x201c;Marpai Administrators&#x201d;), and Maestro Health LLC (&#x201c;Maestro&#x201d;). Marpai Administrators and Maestro are our healthcare payer subsidiaries that provide administration services to self-insured employer groups across the United States. They act as a third-party administrator (&#x201c;TPA&#x201d;) handling all administrative aspects of providing healthcare to self-insured employer groups. We have combined these two businesses to create what we believe to be the Payer of the Future, which has not only the licenses, processes and know-how of a payer but also the latest technology. This combination allows us to differentiate ourselves in the TPA market by delivering a technology-driven service that we believe can lower the overall cost of healthcare while maintaining or improving healthcare outcomes. Marpai Captive, Inc. (&#x201c;Marpai Captive&#x201d;) was founded in March 2022 as a Delaware corporation. Marpai Captive engages in the captive insurance market and commenced operations in the first quarter of 2023 and operated until the fourth quarter of 2025.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Nature of Business&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;Our mission is to improve healthcare for the benefit of (i) our clients who are self-insured employers that pay for their employees&#x2019; healthcare benefits and engage us to administer members&#x2019; healthcare claims, who we refer to as Clients, (ii) employees who receive these healthcare benefits from our clients, who we refer to as Members, and (iii) healthcare providers including doctors, doctor groups, hospitals, clinics, and any other entities providing healthcare services or products, who we refer to as Providers.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;We provide outsourced benefits administration services to Clients in the United States across multiple industries. Our backroom administration and TPA services are supported by a technology platform and a dedicated benefits call center. Under our TPA platform, we provide health and welfare administration, dependent eligibility verification, Consolidated Omnibus Budget Reconciliation Act (&#x201c;COBRA&#x201d;) administration, benefit billing services, and Pharmacy Benefit Management (&#x201c;PBM&#x201d;).&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;"&gt;We continue to monitor the effects of the global macroeconomic environment, including increasing inflationary pressures; supply chain disruptions; tariffs levied by the Trump Administration, social and political issues; regulatory matters, geopolitical tensions; and global security issues. We are also mindful of inflationary pressures on our cost base and are monitoring the impact on customer preferences.&lt;/p&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <srt:CondensedFinancialStatementsTextBlock contextRef="cref_678316177" id="ixv-2792">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&lt;span style="font-weight: bold;"&gt;NOTE 2 &#x2013; UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;"&gt;The accompanying unaudited interim condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (&#x201c;U.S. GAAP&#x201d;) for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, they do not include all the information and footnotes required by U.S. GAAP for complete financial statements. The unaudited interim condensed consolidated financial statements furnished herein reflect all adjustments which are, in the opinion of management, necessary for a fair statement of the results for the interim periods presented. The results of operations of any interim period are not necessarily indicative of the results of operations to be expected for the full fiscal year. The unaudited interim condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and accompanying footnotes included in our Annual Report on Form 10-K for the year ended December 31, 2025.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;The accompanying condensed consolidated financial statements include our accounts and those of our wholly owned subsidiaries.&lt;/p&gt;</srt:CondensedFinancialStatementsTextBlock>
    <us-gaap:SubstantialDoubtAboutGoingConcernTextBlock contextRef="cref_678316177" id="ixv-2800">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&lt;span style="font-weight: bold;"&gt;NOTE 3 &#x2013; LIQUIDITY AND GOING CONCERN&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;"&gt; As shown in the accompanying unaudited interim condensed consolidated financial statements as of June 30, 2026, we had an accumulated deficit of approximately $123.2 million and negative working capital of approximately $14.5 million. At June 30, 2026, we had short-term debt of approximately $4.5 million, long-term debt of approximately $24.4 million, a vendor financing advance of approximately $2.0 million, approximately $1.0 million in connection with an advance of TPA administration fees given to the Company by a related party, and approximately $138 thousand of unrestricted cash on hand. The amount due to the related party was repaid in July 2026. For the six months ended June 30, 2026, we recognized a net loss of approximately $7.8 million and negative cash flows from operations of approximately $4.6 million. We have met our cash needs primarily through proceeds from issuing convertible notes, warrants, preferred stock, and shares of our Class A common stock, par value $0.0001 per share (the &#x201c;common stock&#x201d;), as well as borrowing from various lenders. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;"&gt;We currently project that we will need additional capital to fund our current operations and capital investment requirements until we scale to a revenue level that permits cash self-sufficiency. As a result, we need to raise additional capital or secure debt funding to support on-going operations until such time. This projection is based on our current expectations regarding revenues, expenditures, cash burn rate and other operating assumptions. The sources of this capital are anticipated to be from the sale of equity and/or the issuance of debt. Alternatively, or in addition, we may seek to sell assets which we regard as non-strategic. Any of the foregoing may not be achievable on favorable terms, or at all. Additionally, any debt or equity transactions may cause significant dilution to existing stockholders.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;"&gt;If we are unable to raise additional capital moving forward, our ability to operate in the normal course and continue to invest in our product portfolio may be materially and adversely impacted and we may be forced to scale back operations or divest some or all of our assets.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;As a result of the above, in connection with our assessment of going concern considerations in accordance with Financial Accounting Standards Board&#x2019;s (&#x201c;FASB&#x201d;) Accounting Standards Update (&#x201c;ASU&#x201d;) 2014-15, &#x201c;Disclosures of Uncertainties about an Entity&#x2019;s Ability to Continue as a Going Concern,&#x201d; management has determined that our liquidity condition raises substantial doubt about our ability to continue as a going concern through twelve months from the date these unaudited interim condensed consolidated financial statements are issued. These unaudited interim condensed consolidated financial statements do not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should we be unable to continue as a going concern.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;On July 16, 2026, we entered into Amendment No. 2 (the &#x201c;AXA Amendment&#x201d;) to a purchase agreement with AXA S.A., a French soci&#xe9;t&#xe9; anonyme (&#x201c;AXA&#x201d;). The AXA Amendment amends a Membership Interest Purchase Agreement, dated August 4, 2022, as amended on February 7, 2024 (the &#x201c;AXA Agreement&#x201d;), executed by and among the Company,&#160;XL America Inc., a Delaware corporation, Seaview Re Holdings Inc., a Delaware corporation and AXA, pursuant to which the Company acquired all the membership interests of Maestro Health, LLC.&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; The AXA Amendment also provides that the Company shall make minimum annual payments of not less than $0, $1.0 million, $5.0 million and approximately $22.3 million during the years ending December 31, 2026, 2027, 2028 and 2029, respectively. In addition, the Company agreed not to incur additional indebtedness other than its currently outstanding indebtedness. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; &lt;br/&gt; Subsequent to June 30, 2026, on July 29, 2026, the Company entered into a securities purchase agreement for the issuance and sale of 12,100 shares of newly designated Series A Preferred Stock for aggregate gross proceeds of $12.1 million. As a result of the Offering and pursuant to the terms of the AXA Amendment, approximately $2.45 million became payable to AXA based on the applicable net offering proceeds. Accordingly, approximately $2.45 million of the AXA liability is reflected as a current liability, with the remaining balance reflected as a non-current liability in the accompanying unaudited condensed consolidated balance sheet. &lt;/p&gt;</us-gaap:SubstantialDoubtAboutGoingConcernTextBlock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="cref_685214448"
      decimals="-5"
      id="ixv-7428"
      unitRef="uref_388777331">-123200000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <mrai:WorkingCapital
      contextRef="cref_685214448"
      decimals="-5"
      id="ixv-7429"
      unitRef="uref_388777331">14500000</mrai:WorkingCapital>
    <us-gaap:ShortTermBorrowings
      contextRef="cref_685214448"
      decimals="-5"
      id="ixv-7430"
      unitRef="uref_388777331">4500000</us-gaap:ShortTermBorrowings>
    <us-gaap:LongTermDebt
      contextRef="cref_350394481"
      decimals="-5"
      id="fc_350394481"
      unitRef="uref_388777331">24400000</us-gaap:LongTermDebt>
    <mrai:FinancingAdvance
      contextRef="cref_1112506559"
      decimals="-5"
      id="ixv-7432"
      unitRef="uref_388777331">2000000</mrai:FinancingAdvance>
    <us-gaap:LongTermDebt
      contextRef="cref_2144516316"
      decimals="-5"
      id="ixv-7433"
      unitRef="uref_388777331">1000000</us-gaap:LongTermDebt>
    <mrai:UnrestrictedCash
      contextRef="cref_678316177"
      decimals="-3"
      id="ixv-7434"
      unitRef="uref_388777331">138000</mrai:UnrestrictedCash>
    <us-gaap:NetIncomeLoss
      contextRef="cref_678316177"
      decimals="-5"
      id="ixv-7435"
      unitRef="uref_388777331">-7800000</us-gaap:NetIncomeLoss>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="cref_678316177"
      decimals="-5"
      id="ixv-7436"
      unitRef="uref_388777331">-4600000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="cref_1364625654"
      decimals="4"
      id="ixv-7437"
      unitRef="uref_1972424199">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <mrai:OtherLiabilityAnnualPaymentDueReminderOfFiscalYear
      contextRef="cref_685214448"
      decimals="-6"
      id="ixv-7438"
      unitRef="uref_388777331">0</mrai:OtherLiabilityAnnualPaymentDueReminderOfFiscalYear>
    <mrai:OtherLiabilityAnnualPaymentDueNextTwelveMonths
      contextRef="cref_685214448"
      decimals="-5"
      id="ixv-7439"
      unitRef="uref_388777331">1000000</mrai:OtherLiabilityAnnualPaymentDueNextTwelveMonths>
    <mrai:OtherLiabilityAnnualPaymentDueYearTwo
      contextRef="cref_685214448"
      decimals="-5"
      id="ixv-7440"
      unitRef="uref_388777331">5000000</mrai:OtherLiabilityAnnualPaymentDueYearTwo>
    <mrai:OtherLiabilityAnnualPaymentDueYearThree
      contextRef="cref_685214448"
      decimals="-5"
      id="ixv-7441"
      unitRef="uref_388777331">22300000</mrai:OtherLiabilityAnnualPaymentDueYearThree>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="cref_2006171306"
      decimals="0"
      id="ixv-7442"
      unitRef="uref_917344505">12100</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
      contextRef="cref_2006171306"
      decimals="-5"
      id="ixv-7443"
      unitRef="uref_388777331">12100000</us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock>
    <mrai:NetOfferingProceeds
      contextRef="cref_2006171306"
      decimals="-4"
      id="ixv-7444"
      unitRef="uref_388777331">2450000</mrai:NetOfferingProceeds>
    <us-gaap:OtherLiabilities
      contextRef="cref_1277293661"
      decimals="-4"
      id="ixv-7445"
      unitRef="uref_388777331">2450000</us-gaap:OtherLiabilities>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="cref_678316177" id="ixv-2830">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&lt;span style="font-weight: bold;"&gt;NOTE 4 &#x2013; SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&lt;span style="font-weight: bold;"&gt;Use of Estimates&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;"&gt;The preparation of the condensed consolidated financial statements and related disclosures in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses reported in those condensed consolidated financial statements. Descriptions of our significant accounting policies are discussed in the notes to the consolidated financial statements in our Annual Report on Form 10-K for the year ended December 31, 2025. Management evaluates the related estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, and makes adjustments when facts and circumstances dictate. As future events and their effects cannot be determined with precision, actual results could differ significantly from those estimates and assumptions. Significant changes, if any, in those estimates and assumptions resulting from continuing changes in the economic environment will be reflected in the consolidated financial statements in future periods.&lt;/p&gt;          &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&lt;span style="font-weight: bold;"&gt;Concentrations of Credit Risk&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;"&gt; For the three and six month periods ended June 30, 2026 and June 30, 2025, we had no single customer that accounted for more than 10% of total revenue. At June 30, 2026, two customers accounted for 18.0% and 16.0% of accounts receivable, respectively. At December 31, 2025, two customers accounted for 19.5% and 19.1% of accounts receivable, respectively. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&lt;span style="font-weight: bold;"&gt;Restricted Cash&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;"&gt;Restricted cash balances are composed of funds held on behalf of clients in a fiduciary capacity, cash in a money market account as required by a credit card company for collateral, and a certificate of deposit (&#x201c;CD&#x201d;) held for collateral for a letter of credit. Fiduciary funds generally cannot be utilized for general corporate purposes and are not a source of liquidity for us. A corresponding fiduciary obligation, included in current liabilities in the accompanying condensed consolidated balance sheets, exists for disbursements to be made on behalf of the clients and may be more than the restricted cash balance if payment from customers has not been received.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&lt;span style="font-weight: bold;"&gt;Capitalized Software&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;"&gt; We comply with the guidance of Accounting Standards Codification (&#x201c;ASC&#x201d;) Topic 350-40, &#x201c;Intangibles&#x2014;Goodwill and Other&#x2014;Internal Use Software&#x201d;, in accounting for our internally developed system projects that it utilizes to provide our services to customers. These system projects generally relate to our software that is not intended for sale or otherwise marketed. Internal and external costs incurred during the preliminary project stage are expensed as they are incurred. Once a project has reached the development stage, we capitalize direct internal and external costs until the software is substantially complete and ready for its intended use. Costs for upgrades and enhancements are capitalized, whereas costs incurred for maintenance are expensed as incurred. These capitalized software costs are amortized on a project-by-project basis over the expected economic life of the underlying software on a straight-line basis, which is generally three to five years. Amortization commences when the software is available for its intended use. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&lt;span style="font-weight: bold;"&gt;Revenue Recognition&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Third Party Administrator Revenue&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;"&gt;Revenue is recognized when control of the promised services is transferred to our customers in an amount that reflects the consideration expected to be entitled to in exchange for those services. As we complete our performance obligations, we have an unconditional right to consideration, as outlined in our contracts.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Contract Balances&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;"&gt; At June 30, 2026 and December 31, 2025, the balances of our accounts receivable from contracts with customers, net of related allowances for credit losses, were $1.0 million and $697 thousand, respectively, and the balances of our unbilled receivables from contracts with customers were $1.1 million and $280 thousand, respectively. When we receive consideration from a customer prior to providing services to the customer under the terms of the customer contracts, we record deferred revenue on our condensed consolidated balance sheet, which represents a contract liability. At June 30, 2026 and December 31, 2025, the balances of deferred revenue were $317 thousand and $89 thousand, respectively. The deferred revenue balance includes $317 thousand as of June 30, 2026, which is related to advance payments received from a related party in connection with TPA administration fees, see Note 13. The full deferred revenue balance as of December 31, 2025 was recognized during the six months ended June 30, 2026. We anticipate that we will satisfy all of our performance obligations associated with our contract liabilities within a year. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;"&gt; We also provide certain performance guarantees under contracts with customers. Customers may be entitled to receive compensation if we fail to meet the guarantees. Actual performance is compared to the contractual guarantee for each measure throughout the period. We had performance guarantee liabilities of $204 thousand and $199 thousand as of June 30, 2026 and December 31, 2025, respectively, which are included in accrued expenses on the accompanying condensed consolidated balance sheets. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&lt;/p&gt;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Significant Payment Terms&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;"&gt;Generally, our accounts receivable are expected to be collected within 30 days. Invoices for services are typically sent to the customer on the 15th day of the month prior to the service month with a 15-day payment term. We do not offer discounts if the customer pays some or all of the invoiced amount prior to the due date.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;"&gt;Consideration paid for services rendered by us is nonrefundable. Therefore, at the time revenue is recognized, we do not estimate expected refunds for services.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;"&gt;We use the practical expedient and do not account for significant financing components because the period between recognition and collection does not exceed one year for all of our contracts.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Timing of Performance Obligations&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;"&gt;All of our contracts with customers obligate us to perform services. Services provided include health and welfare administration, dependent eligibility verification, COBRA administration, and benefit billing. Revenue is recognized over time as services are provided as the performance obligations are satisfied through the effort expended to research, investigate, evaluate, document, and report claims, and control of these services is transferred to the customer. We have the right to receive payment for all services rendered.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Determining and Allocating the Transaction Price&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;"&gt;The transaction price of a contract is the amount of consideration to which we expect to be entitled in exchange for providing promised services to a customer.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;"&gt;To determine the transaction price of a contract, we consider our customary business practices and the terms of the contract. For the purpose of determining transaction prices, we assume that the services will be provided to the customer as promised in accordance with existing contracts and that the contracts will not be canceled, renewed, or modified.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;"&gt;Our contracts with customers have fixed fee prices that are denominated per covered employee per month. We include amounts of variable consideration in a contract&#x2019;s transaction price only to the extent that it is probable that the amounts will not be subject to significant reversals (that is, downward adjustments to revenue recognized for satisfied performance obligations). In determining amounts of variable consideration to include in a contract&#x2019;s transaction price, we rely on our experience and other evidence that supports our qualitative assessment of whether revenue would be subject to a significant reversal. We consider all the facts and circumstances associated with both the risk of a revenue reversal arising from an uncertain future event and the magnitude of the reversal if that uncertain event were to occur.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Captive Revenue&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;All general insurance premiums pertain to annual policies and are reflected in income on a pro-rata basis.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Loss and Loss Adjustment Expenses&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;"&gt;The establishment of loss reserves by the primary insurer is a reasonably complex and dynamic process influenced by numerous factors. These factors principally include past experience with like claims. Consequently, the reserves established are a reflection of the opinions of a large number of persons and we are exposed to the possibility of higher or lower than anticipated loss cost due to real expense.&lt;/p&gt;          &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&lt;span style="font-weight: bold;"&gt;Earnings (Loss) Per Share (&#x201c;EPS&#x201d;)&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;"&gt; Basic earnings (loss) per share is computed by dividing net income (loss) available to common stockholders by the weighted average number of outstanding shares of common stock for the period, considering the effect of participating securities. Diluted earnings (loss) per share is calculated by dividing net earnings (loss) by the weighted average number of shares of common stock and dilutive common stock equivalents outstanding. During the periods when they are anti-dilutive, shares of common stock equivalents, if any, are not considered in the computation. All securities that meet the definition of a participating security, irrespective of whether the securities are convertible, nonconvertible, or potential common stock securities, shall be included in the computation of basic EPS using the two-class method. However, when the different classes of units have identical rights and privileges except voting rights, whereby they share equally in dividends and residual net assets on a per unit basis, the classes can be combined and presented as one class for EPS purposes. As of June 30, 2026 and 2025, there were no preferred stock outstanding. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;"&gt; At June 30, 2026 and 2025, there were 11,236,542 and 4,756,572 common stock equivalents outstanding, respectively. For the six months ended June 30, 2026 and 2025, these potential shares were excluded from the shares used to calculate diluted net loss per share as their effect would have been antidilutive. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&lt;span style="font-weight: bold;"&gt;Recently Issued Accounting Pronouncements&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;"&gt;In December 2023, the FASB issued ASU 2023-09, &#x201c;Income Taxes (Topic 740): Improvements to Income Tax Disclosures,&#x201d; which requires disaggregated information about a reporting entity&#x2019;s effective tax rate reconciliation as well as information on income taxes paid. The standard is intended to benefit investors by providing more detailed income tax disclosures that would be useful in making capital allocation decisions. As an Emerging Growth Company, the standard is effective for fiscal years beginning after December 15, 2025. The Company adopted ASU 2023-09 as of January 1, 2026, on a prospective basis and it did not have an impact on its financial position and results of operations.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;"&gt;In November 2024, the FASB issued ASU 2024-03, &#x201c;Expense Disaggregation Disclosures (Topic 220): Disaggregation of Income Statement Expenses&#x201d; (&#x201c;ASU 2024-03&#x201d;), which requires public entities to disclose additional information that disaggregates certain expense captions into specified categories in the notes to the consolidated financial statements. The new standard is effective for fiscal years beginning after December 15, 2026, and interim periods after December 15, 2027, with early adoption permitted. The disclosure updates are required to be applied prospectively with the option for retrospective application. We are currently evaluating the impact the amended guidance will have on our disclosures.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;"&gt;In November 2024, the FASB issued ASU 2024-04, Debt - Debt with Conversions and Other Options (Subtopic 470-20): Induced Conversions of Convertible Debt Instruments (&#x201c;ASU 2024-04&#x201d;). ASU 2024-04 clarifies the requirements for determining whether certain settlements of convertible debt instruments, including convertible debt instruments with cash conversion features or convertible debt instruments that are not currently convertible, should be accounted for as an induced conversion. The requirements of ASU 2024-04 are effective for us for fiscal years beginning after December 15, 2025, and interim periods within those periods. Early adoption is permitted for all entities that have adopted the amendments in ASU 2020-06 and can be applied on a prospective or retrospective basis. The Company adopted ASU 2024-04 as of January 1, 2026, on a prospective basis and it did not have an impact on its financial position and results of operations.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;"&gt;In July 2025, the FASB issued ASU&#x2006;2025-05, Financial Instruments &#x2013; Credit Losses (Topic 326) (&#x201c;ASU 2025-05&#x201d;) which provides optional guidance relating to the estimation of expected credit losses on current accounts receivable and current contract assets. This guidance permits entities to apply a practical expedient when estimating credit losses that assumes that current conditions as of the balance sheet date do not change for the remaining life of the asset. ASU&#x2006;2025-05 is effective for annual reporting periods beginning after December&#x2006;15, 2025, and interim reporting periods within those annual reporting periods, with early adoption permitted, and should be applied prospectively. The Company adopted ASU 2025-05 as of January 1, 2026, electing the practical expedient method and it did not have a material impact on its financial position and results of operations.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;"&gt;In September 2025, the FASB issued ASU 2025-06, Intangibles&#x2014;Goodwill and Other&#x2014;Internal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software (&#x201c;ASU 2025-06&#x201d;), to modernize the accounting guidance for the costs to develop software for internal use. The standard applies to costs incurred to develop or obtain software for internal use. ASU 2025-06 amends the existing standard that refers to various stages of a software development project to align better with current software development methods, such as agile programming. Under the new standard, entities will commence capitalizing eligible costs when (i) management has authorized and committed to funding the software project, and (ii) it is probable that the project will be completed and the software will be used to perform the function intended. The new standard also supersedes the guidance related to costs incurred to develop a website. ASU 2025-06 guidance is effective for annual periods beginning after December 15, 2027, and interim reporting periods within those annual reporting periods. The guidance can be applied on a prospective basis, a modified basis for in-process projects or on a retrospective basis. We are currently evaluating the impact of this accounting standard on our condensed consolidated financial statements.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;"&gt;In April 2026, the FASB issued ASU 2026-01, Equity (Topic 505): Initial Measurement of Paid-in-Kind Dividends on Equity-Classified Preferred Stock. The amendments in this update require entities to initially measure paid-in-kind (&#x201c;PIK&#x201d;) dividends on equity-classified preferred stock using the PIK dividend rate stated in the preferred stock agreement, rather than at fair value. This ASU is effective for annual periods beginning after December 15, 2026, including interim periods within those fiscal years, with early adoption permitted. We are currently evaluating the impact of this accounting standard on our condensed consolidated financial statements.&lt;/p&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:UseOfEstimates contextRef="cref_678316177" id="ixv-2834">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&lt;span style="font-weight: bold;"&gt;Use of Estimates&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;"&gt;The preparation of the condensed consolidated financial statements and related disclosures in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses reported in those condensed consolidated financial statements. Descriptions of our significant accounting policies are discussed in the notes to the consolidated financial statements in our Annual Report on Form 10-K for the year ended December 31, 2025. Management evaluates the related estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, and makes adjustments when facts and circumstances dictate. As future events and their effects cannot be determined with precision, actual results could differ significantly from those estimates and assumptions. Significant changes, if any, in those estimates and assumptions resulting from continuing changes in the economic environment will be reflected in the consolidated financial statements in future periods.&lt;/p&gt;</us-gaap:UseOfEstimates>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="cref_678316177" id="ixv-2852">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&lt;span style="font-weight: bold;"&gt;Concentrations of Credit Risk&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;"&gt; For the three and six month periods ended June 30, 2026 and June 30, 2025, we had no single customer that accounted for more than 10% of total revenue. At June 30, 2026, two customers accounted for 18.0% and 16.0% of accounts receivable, respectively. At December 31, 2025, two customers accounted for 19.5% and 19.1% of accounts receivable, respectively. &lt;/p&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="cref_283139205"
      decimals="3"
      id="ixv-7446"
      unitRef="uref_2099918223">0.18</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="cref_970781207"
      decimals="3"
      id="ixv-7447"
      unitRef="uref_2099918223">0.16</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="cref_1975347265"
      decimals="3"
      id="ixv-7448"
      unitRef="uref_2099918223">0.195</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="cref_939099532"
      decimals="3"
      id="ixv-7449"
      unitRef="uref_2099918223">0.191</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy contextRef="cref_678316177" id="ixv-2858">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&lt;span style="font-weight: bold;"&gt;Restricted Cash&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;"&gt;Restricted cash balances are composed of funds held on behalf of clients in a fiduciary capacity, cash in a money market account as required by a credit card company for collateral, and a certificate of deposit (&#x201c;CD&#x201d;) held for collateral for a letter of credit. Fiduciary funds generally cannot be utilized for general corporate purposes and are not a source of liquidity for us. A corresponding fiduciary obligation, included in current liabilities in the accompanying condensed consolidated balance sheets, exists for disbursements to be made on behalf of the clients and may be more than the restricted cash balance if payment from customers has not been received.&lt;/p&gt;</us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy>
    <us-gaap:InternalUseSoftwarePolicy contextRef="cref_678316177" id="ixv-2864">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&lt;span style="font-weight: bold;"&gt;Capitalized Software&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;"&gt; We comply with the guidance of Accounting Standards Codification (&#x201c;ASC&#x201d;) Topic 350-40, &#x201c;Intangibles&#x2014;Goodwill and Other&#x2014;Internal Use Software&#x201d;, in accounting for our internally developed system projects that it utilizes to provide our services to customers. These system projects generally relate to our software that is not intended for sale or otherwise marketed. Internal and external costs incurred during the preliminary project stage are expensed as they are incurred. Once a project has reached the development stage, we capitalize direct internal and external costs until the software is substantially complete and ready for its intended use. Costs for upgrades and enhancements are capitalized, whereas costs incurred for maintenance are expensed as incurred. These capitalized software costs are amortized on a project-by-project basis over the expected economic life of the underlying software on a straight-line basis, which is generally three to five years. Amortization commences when the software is available for its intended use. &lt;/p&gt;</us-gaap:InternalUseSoftwarePolicy>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="cref_1940157768" id="ixv-7450">P3Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="cref_781661425" id="ixv-7451">P5Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock contextRef="cref_678316177" id="ixv-2870">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&lt;span style="font-weight: bold;"&gt;Revenue Recognition&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Third Party Administrator Revenue&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;"&gt;Revenue is recognized when control of the promised services is transferred to our customers in an amount that reflects the consideration expected to be entitled to in exchange for those services. As we complete our performance obligations, we have an unconditional right to consideration, as outlined in our contracts.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Contract Balances&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;"&gt; At June 30, 2026 and December 31, 2025, the balances of our accounts receivable from contracts with customers, net of related allowances for credit losses, were $1.0 million and $697 thousand, respectively, and the balances of our unbilled receivables from contracts with customers were $1.1 million and $280 thousand, respectively. When we receive consideration from a customer prior to providing services to the customer under the terms of the customer contracts, we record deferred revenue on our condensed consolidated balance sheet, which represents a contract liability. At June 30, 2026 and December 31, 2025, the balances of deferred revenue were $317 thousand and $89 thousand, respectively. The deferred revenue balance includes $317 thousand as of June 30, 2026, which is related to advance payments received from a related party in connection with TPA administration fees, see Note 13. The full deferred revenue balance as of December 31, 2025 was recognized during the six months ended June 30, 2026. We anticipate that we will satisfy all of our performance obligations associated with our contract liabilities within a year. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;"&gt; We also provide certain performance guarantees under contracts with customers. Customers may be entitled to receive compensation if we fail to meet the guarantees. Actual performance is compared to the contractual guarantee for each measure throughout the period. We had performance guarantee liabilities of $204 thousand and $199 thousand as of June 30, 2026 and December 31, 2025, respectively, which are included in accrued expenses on the accompanying condensed consolidated balance sheets. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Significant Payment Terms&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;"&gt;Generally, our accounts receivable are expected to be collected within 30 days. Invoices for services are typically sent to the customer on the 15th day of the month prior to the service month with a 15-day payment term. We do not offer discounts if the customer pays some or all of the invoiced amount prior to the due date.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;"&gt;Consideration paid for services rendered by us is nonrefundable. Therefore, at the time revenue is recognized, we do not estimate expected refunds for services.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;"&gt;We use the practical expedient and do not account for significant financing components because the period between recognition and collection does not exceed one year for all of our contracts.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Timing of Performance Obligations&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;"&gt;All of our contracts with customers obligate us to perform services. Services provided include health and welfare administration, dependent eligibility verification, COBRA administration, and benefit billing. Revenue is recognized over time as services are provided as the performance obligations are satisfied through the effort expended to research, investigate, evaluate, document, and report claims, and control of these services is transferred to the customer. We have the right to receive payment for all services rendered.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Determining and Allocating the Transaction Price&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;"&gt;The transaction price of a contract is the amount of consideration to which we expect to be entitled in exchange for providing promised services to a customer.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;"&gt;To determine the transaction price of a contract, we consider our customary business practices and the terms of the contract. For the purpose of determining transaction prices, we assume that the services will be provided to the customer as promised in accordance with existing contracts and that the contracts will not be canceled, renewed, or modified.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;"&gt;Our contracts with customers have fixed fee prices that are denominated per covered employee per month. We include amounts of variable consideration in a contract&#x2019;s transaction price only to the extent that it is probable that the amounts will not be subject to significant reversals (that is, downward adjustments to revenue recognized for satisfied performance obligations). In determining amounts of variable consideration to include in a contract&#x2019;s transaction price, we rely on our experience and other evidence that supports our qualitative assessment of whether revenue would be subject to a significant reversal. We consider all the facts and circumstances associated with both the risk of a revenue reversal arising from an uncertain future event and the magnitude of the reversal if that uncertain event were to occur.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Captive Revenue&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;All general insurance premiums pertain to annual policies and are reflected in income on a pro-rata basis.&lt;/p&gt;</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <mrai:AmountsOverFederallyInsuredLimits
      contextRef="cref_678316177"
      decimals="-5"
      id="ixv-7453"
      unitRef="uref_388777331">1000000</mrai:AmountsOverFederallyInsuredLimits>
    <mrai:AmountsOverFederallyInsuredLimits
      contextRef="cref_1046745539"
      decimals="-3"
      id="ixv-7454"
      unitRef="uref_388777331">697000</mrai:AmountsOverFederallyInsuredLimits>
    <us-gaap:UnbilledReceivablesCurrent
      contextRef="cref_685214448"
      decimals="-5"
      id="ixv-7455"
      unitRef="uref_388777331">1100000</us-gaap:UnbilledReceivablesCurrent>
    <us-gaap:UnbilledReceivablesCurrent
      contextRef="cref_560512737"
      decimals="-3"
      id="ixv-7456"
      unitRef="uref_388777331">280000</us-gaap:UnbilledReceivablesCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="cref_685214448"
      decimals="-3"
      id="ixv-7457"
      unitRef="uref_388777331">317000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="cref_560512737"
      decimals="-3"
      id="ixv-7458"
      unitRef="uref_388777331">89000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <mrai:PerformanceGuaranteeLiabilitiesCurrent
      contextRef="cref_685214448"
      decimals="-3"
      id="ixv-7459"
      unitRef="uref_388777331">204000</mrai:PerformanceGuaranteeLiabilitiesCurrent>
    <mrai:PerformanceGuaranteeLiabilitiesCurrent
      contextRef="cref_560512737"
      decimals="-3"
      id="ixv-7460"
      unitRef="uref_388777331">199000</mrai:PerformanceGuaranteeLiabilitiesCurrent>
    <mrai:LossAndLossAdjustmentExpensesPolicyTextBlock contextRef="cref_678316177" id="ixv-2933">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Loss and Loss Adjustment Expenses&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;"&gt;The establishment of loss reserves by the primary insurer is a reasonably complex and dynamic process influenced by numerous factors. These factors principally include past experience with like claims. Consequently, the reserves established are a reflection of the opinions of a large number of persons and we are exposed to the possibility of higher or lower than anticipated loss cost due to real expense.&lt;/p&gt;</mrai:LossAndLossAdjustmentExpensesPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="cref_678316177" id="ixv-2952">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&lt;span style="font-weight: bold;"&gt;Earnings (Loss) Per Share (&#x201c;EPS&#x201d;)&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;"&gt; Basic earnings (loss) per share is computed by dividing net income (loss) available to common stockholders by the weighted average number of outstanding shares of common stock for the period, considering the effect of participating securities. Diluted earnings (loss) per share is calculated by dividing net earnings (loss) by the weighted average number of shares of common stock and dilutive common stock equivalents outstanding. During the periods when they are anti-dilutive, shares of common stock equivalents, if any, are not considered in the computation. All securities that meet the definition of a participating security, irrespective of whether the securities are convertible, nonconvertible, or potential common stock securities, shall be included in the computation of basic EPS using the two-class method. However, when the different classes of units have identical rights and privileges except voting rights, whereby they share equally in dividends and residual net assets on a per unit basis, the classes can be combined and presented as one class for EPS purposes. As of June 30, 2026 and 2025, there were no preferred stock outstanding. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;"&gt; At June 30, 2026 and 2025, there were 11,236,542 and 4,756,572 common stock equivalents outstanding, respectively. For the six months ended June 30, 2026 and 2025, these potential shares were excluded from the shares used to calculate diluted net loss per share as their effect would have been antidilutive. &lt;/p&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="cref_685214448"
      decimals="0"
      id="ixv-7461"
      unitRef="uref_917344505">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="cref_560512737"
      decimals="0"
      id="ixv-7462"
      unitRef="uref_917344505">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="cref_1731395949"
      decimals="0"
      id="ixv-7463"
      unitRef="uref_917344505">11236542</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="cref_717232960"
      decimals="0"
      id="ixv-7464"
      unitRef="uref_917344505">4756572</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="cref_678316177" id="ixv-2960">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&lt;span style="font-weight: bold;"&gt;Recently Issued Accounting Pronouncements&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;"&gt;In December 2023, the FASB issued ASU 2023-09, &#x201c;Income Taxes (Topic 740): Improvements to Income Tax Disclosures,&#x201d; which requires disaggregated information about a reporting entity&#x2019;s effective tax rate reconciliation as well as information on income taxes paid. The standard is intended to benefit investors by providing more detailed income tax disclosures that would be useful in making capital allocation decisions. As an Emerging Growth Company, the standard is effective for fiscal years beginning after December 15, 2025. The Company adopted ASU 2023-09 as of January 1, 2026, on a prospective basis and it did not have an impact on its financial position and results of operations.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;"&gt;In November 2024, the FASB issued ASU 2024-03, &#x201c;Expense Disaggregation Disclosures (Topic 220): Disaggregation of Income Statement Expenses&#x201d; (&#x201c;ASU 2024-03&#x201d;), which requires public entities to disclose additional information that disaggregates certain expense captions into specified categories in the notes to the consolidated financial statements. The new standard is effective for fiscal years beginning after December 15, 2026, and interim periods after December 15, 2027, with early adoption permitted. The disclosure updates are required to be applied prospectively with the option for retrospective application. We are currently evaluating the impact the amended guidance will have on our disclosures.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;"&gt;In November 2024, the FASB issued ASU 2024-04, Debt - Debt with Conversions and Other Options (Subtopic 470-20): Induced Conversions of Convertible Debt Instruments (&#x201c;ASU 2024-04&#x201d;). ASU 2024-04 clarifies the requirements for determining whether certain settlements of convertible debt instruments, including convertible debt instruments with cash conversion features or convertible debt instruments that are not currently convertible, should be accounted for as an induced conversion. The requirements of ASU 2024-04 are effective for us for fiscal years beginning after December 15, 2025, and interim periods within those periods. Early adoption is permitted for all entities that have adopted the amendments in ASU 2020-06 and can be applied on a prospective or retrospective basis. The Company adopted ASU 2024-04 as of January 1, 2026, on a prospective basis and it did not have an impact on its financial position and results of operations.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;"&gt;In July 2025, the FASB issued ASU&#x2006;2025-05, Financial Instruments &#x2013; Credit Losses (Topic 326) (&#x201c;ASU 2025-05&#x201d;) which provides optional guidance relating to the estimation of expected credit losses on current accounts receivable and current contract assets. This guidance permits entities to apply a practical expedient when estimating credit losses that assumes that current conditions as of the balance sheet date do not change for the remaining life of the asset. ASU&#x2006;2025-05 is effective for annual reporting periods beginning after December&#x2006;15, 2025, and interim reporting periods within those annual reporting periods, with early adoption permitted, and should be applied prospectively. The Company adopted ASU 2025-05 as of January 1, 2026, electing the practical expedient method and it did not have a material impact on its financial position and results of operations.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;"&gt;In September 2025, the FASB issued ASU 2025-06, Intangibles&#x2014;Goodwill and Other&#x2014;Internal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software (&#x201c;ASU 2025-06&#x201d;), to modernize the accounting guidance for the costs to develop software for internal use. The standard applies to costs incurred to develop or obtain software for internal use. ASU 2025-06 amends the existing standard that refers to various stages of a software development project to align better with current software development methods, such as agile programming. Under the new standard, entities will commence capitalizing eligible costs when (i) management has authorized and committed to funding the software project, and (ii) it is probable that the project will be completed and the software will be used to perform the function intended. The new standard also supersedes the guidance related to costs incurred to develop a website. ASU 2025-06 guidance is effective for annual periods beginning after December 15, 2027, and interim reporting periods within those annual reporting periods. The guidance can be applied on a prospective basis, a modified basis for in-process projects or on a retrospective basis. We are currently evaluating the impact of this accounting standard on our condensed consolidated financial statements.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;"&gt;In April 2026, the FASB issued ASU 2026-01, Equity (Topic 505): Initial Measurement of Paid-in-Kind Dividends on Equity-Classified Preferred Stock. The amendments in this update require entities to initially measure paid-in-kind (&#x201c;PIK&#x201d;) dividends on equity-classified preferred stock using the PIK dividend rate stated in the preferred stock agreement, rather than at fair value. This ASU is effective for annual periods beginning after December 15, 2026, including interim periods within those fiscal years, with early adoption permitted. We are currently evaluating the impact of this accounting standard on our condensed consolidated financial statements.&lt;/p&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock contextRef="cref_678316177" id="ixv-2987">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&lt;span style="font-weight: bold;"&gt;NOTE 5 &#x2013; CAPITALIZED SOFTWARE&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;Capitalized software consists of the following at:&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;(in thousands)&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center;"&gt;June 30,&lt;/td&gt; &lt;td style="font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center;"&gt;December 31,&lt;/td&gt; &lt;td style="font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;2026&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;2025&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="width: 76%; text-align: left;"&gt;Capitalized software&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;3,836&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;3,836&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left; padding-bottom: 1.5pt;"&gt;Accumulated amortization&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;(3,836&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;)&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;(3,776&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: left; padding-bottom: 4pt;"&gt;Capitalized software, net&lt;/td&gt; &lt;td style="padding-bottom: 4pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1199039503;"&gt;-&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 4pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;60&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt; Amortization expense was $60&#160;thousand and $214&#160;thousand for the six months ended June 30, 2026 and 2025, respectively. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt; Amortization expense was $0 and $107 thousand for the three months ended June 30, 2026 and 2025, respectively. &lt;/p&gt;</us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock>
    <us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock contextRef="cref_678316177" id="ixv-2991">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;Capitalized software consists of the following at:&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center;"&gt;June 30,&lt;/td&gt; &lt;td style="font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center;"&gt;December 31,&lt;/td&gt; &lt;td style="font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;2026&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;2025&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="width: 76%; text-align: left;"&gt;Capitalized software&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;3,836&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;3,836&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left; padding-bottom: 1.5pt;"&gt;Accumulated amortization&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;(3,836&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;)&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;(3,776&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: left; padding-bottom: 4pt;"&gt;Capitalized software, net&lt;/td&gt; &lt;td style="padding-bottom: 4pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1199039503;"&gt;-&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 4pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;60&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock>
    <us-gaap:CapitalizedComputerSoftwareGross
      contextRef="cref_685214448"
      decimals="-3"
      id="ixv-7465"
      unitRef="uref_388777331">3836000</us-gaap:CapitalizedComputerSoftwareGross>
    <us-gaap:CapitalizedComputerSoftwareGross
      contextRef="cref_560512737"
      decimals="-3"
      id="ixv-7466"
      unitRef="uref_388777331">3836000</us-gaap:CapitalizedComputerSoftwareGross>
    <us-gaap:CapitalizedComputerSoftwareAccumulatedAmortization
      contextRef="cref_685214448"
      decimals="-3"
      id="ixv-7467"
      unitRef="uref_388777331">3836000</us-gaap:CapitalizedComputerSoftwareAccumulatedAmortization>
    <us-gaap:CapitalizedComputerSoftwareAccumulatedAmortization
      contextRef="cref_560512737"
      decimals="-3"
      id="ixv-7468"
      unitRef="uref_388777331">3776000</us-gaap:CapitalizedComputerSoftwareAccumulatedAmortization>
    <us-gaap:CapitalizedComputerSoftwareNet
      contextRef="cref_560512737"
      decimals="-3"
      id="ixv-7469"
      unitRef="uref_388777331">60000</us-gaap:CapitalizedComputerSoftwareNet>
    <us-gaap:CapitalizedComputerSoftwareAmortization1
      contextRef="cref_678316177"
      decimals="-3"
      id="ixv-7470"
      unitRef="uref_388777331">60000</us-gaap:CapitalizedComputerSoftwareAmortization1>
    <us-gaap:CapitalizedComputerSoftwareAmortization1
      contextRef="cref_968639710"
      decimals="-3"
      id="ixv-7471"
      unitRef="uref_388777331">214000</us-gaap:CapitalizedComputerSoftwareAmortization1>
    <us-gaap:CapitalizedComputerSoftwareAmortization1
      contextRef="cref_1864859878"
      decimals="-3"
      id="ixv-7472"
      unitRef="uref_388777331">0</us-gaap:CapitalizedComputerSoftwareAmortization1>
    <us-gaap:CapitalizedComputerSoftwareAmortization1
      contextRef="cref_696692331"
      decimals="-3"
      id="ixv-7473"
      unitRef="uref_388777331">107000</us-gaap:CapitalizedComputerSoftwareAmortization1>
    <mrai:LossAndLossAdjustmentExpensesTextBlock contextRef="cref_678316177" id="ixv-3051">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&lt;span style="font-weight: bold;"&gt;NOTE 6 &#x2013; LOSS AND LOSS ADJUSTMENT EXPENSES&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;The following tables show changes in aggregate reserves for our loss and loss adjustment expenses for the three and six month periods ending June 30, 2026 and June 30, 2025:&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;(in thousands)&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;2026&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;2025&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="width: 76%; font-weight: bold;"&gt;Net reserves at April 1,&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1527964499;"&gt;-&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;28&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt;&lt;td style="font-weight: bold; text-align: left;"&gt;Incurred loss and loss adjustment expenses&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: left;"&gt;Provisions for insured events of the current year&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1032511269;"&gt;-&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1151601350;"&gt;-&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left; padding-bottom: 1.5pt;"&gt;Change in provision for insured events of prior year&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_817278067;"&gt;-&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;-&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: left;"&gt;Total incurred loss and loss adjustment expense&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_293986317;"&gt;-&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_796188153;"&gt;-&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt;&lt;td style="font-weight: bold;"&gt;Payments&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: left;"&gt;Loss and loss adjustment expenses attributable to insured events of the current year&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_713713788;"&gt;-&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_727231070;"&gt;-&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left; padding-bottom: 1.5pt;"&gt;Loss and loss adjustment expenses attributable to insured events of the prior year&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1866867441;"&gt;-&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1834583089;"&gt;-&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: left; padding-bottom: 1.5pt;"&gt;Total payments&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1425340663;"&gt;-&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_928778361;"&gt;-&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="font-weight: bold; padding-bottom: 4pt;"&gt;Net reserves at June 30,&lt;/td&gt; &lt;td style="padding-bottom: 4pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1118269202;"&gt;-&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 4pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;28&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;2026&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;2025&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="width: 76%; font-weight: bold;"&gt;Net reserves at January 1,&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1595692465;"&gt;-&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;201&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt;&lt;td style="font-weight: bold; text-align: left;"&gt;Incurred loss and loss adjustment expenses&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: left;"&gt;Provisions for insured events of the current year&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_718799904;"&gt;-&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_675325791;"&gt;-&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left; padding-bottom: 1.5pt;"&gt;Change in provision for insured events of prior year&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_402515611;"&gt;-&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;(161&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: left;"&gt;Total incurred loss and loss adjustment expense&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_2024516547;"&gt;-&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;(161&lt;/td&gt; &lt;td style="text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt;&lt;td style="font-weight: bold;"&gt;Payments&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: left;"&gt;Loss and loss adjustment expenses attributable to insured events of the current year&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1254963063;"&gt;-&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_979518578;"&gt;-&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left; padding-bottom: 1.5pt;"&gt;Loss and loss adjustment expenses attributable to insured events of the prior year&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_201969355;"&gt;-&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;12&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: left; padding-bottom: 1.5pt;"&gt;Total payments&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_2010329833;"&gt;-&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;12&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="font-weight: bold; padding-bottom: 4pt;"&gt;Net reserves at June 30,&lt;/td&gt; &lt;td style="padding-bottom: 4pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_830608628;"&gt;-&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 4pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;28&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</mrai:LossAndLossAdjustmentExpensesTextBlock>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="cref_1226747563"
      decimals="-3"
      id="ixv-7474"
      unitRef="uref_388777331">28000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="cref_156869995"
      decimals="-3"
      id="ixv-7475"
      unitRef="uref_388777331">28000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="cref_1534084021"
      decimals="-3"
      id="ixv-7476"
      unitRef="uref_388777331">201000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense
      contextRef="cref_968639710"
      decimals="-3"
      id="ixv-7477"
      unitRef="uref_388777331">-161000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1
      contextRef="cref_968639710"
      decimals="-3"
      id="ixv-7478"
      unitRef="uref_388777331">-161000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1
      contextRef="cref_968639710"
      decimals="-3"
      id="ixv-7479"
      unitRef="uref_388777331">12000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1>
    <us-gaap:PaymentsForLossesAndLossAdjustmentExpense
      contextRef="cref_968639710"
      decimals="-3"
      id="ixv-7480"
      unitRef="uref_388777331">12000</us-gaap:PaymentsForLossesAndLossAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="cref_1226747563"
      decimals="-3"
      id="ixv-7481"
      unitRef="uref_388777331">28000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:DebtDisclosureTextBlock contextRef="cref_678316177" id="ixv-3315">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&lt;span style="font-weight: bold;"&gt;NOTE 7 &#x2013; CONVERTIBLE DEBENTURES&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;"&gt; On April 15, 2024, we entered into a Securities Purchase Agreement (the &#x201c;JGB Purchase Agreement&#x201d;) with each of the Purchasers thereto (the &#x201c;Purchasers&#x201d;) and JGB Collateral LLC (&#x201c;JGB&#x201d;), a Delaware limited liability company, as collateral agent for the Purchasers (the &#x201c;Agent&#x201d;). Pursuant to the terms of the JGB Purchase Agreement, on April 15, 2024, we issued the Senior Secured Convertible Debentures (the &#x201c;Debentures&#x201d;) due on April 15, 2027 for a principal sum of $11.8 million, subject to the redemption of $5 million at our election. In accordance with the JGB Purchase Agreement, JGB purchased an aggregate of $6.8 million in principal amount of the Debentures, in exchange for $6.0 million in funding. Effective June 21, 2024, we elected not to redeem up to an aggregate of $5.0 million of the Debentures. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;"&gt; On December 30, 2024, we entered into amendments to the JGB Purchase Agreement (the &#x201c;Amendment Agreement&#x201d;) and the Debentures (each, a &#x201c;Debenture Amendment&#x201d; and collectively, the &#x201c;Debenture Amendments&#x201d;), with the Purchasers, the Agent and the other parties thereto, as applicable, to, among other things, sell Debentures up to an additional aggregate principal amount of $5.4 million, for total proceeds of $5 million (the &#x201c;Additional Investment&#x201d;). Pursuant to the terms of the Amendment Agreement and the Debenture Amendments, $2.0 million of the Additional Investment was delivered to us at closing, and the remaining $3.0 million of the Additional Investment was held in escrow pending satisfaction of certain terms and conditions specified in the Amendment Agreement and the Debenture Amendments. On January 17, 2025, we received proceeds of $3.0 million from the Additional Investment that had been held in escrow pending satisfaction of certain terms and conditions specified in the Amendment Agreement and the Debenture Amendments. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;"&gt; Pursuant to the Debenture Amendments, the Debentures bear interest at an annual rate of 14%, require monthly principal payments of $250 thousand beginning in January 2025, and have a maturity date of April 15, 2027. The first $6.8 million is convertible, in whole or in part, at any time after their issuance date at the option of the Purchasers, into shares of our common stock at a conversion price equal to $3.00 per share (the &#x201c;Conversion Price&#x201d;), subject to adjustment as set forth in the Debentures. The Conversion Price of the Debentures is subject to anti-dilution protection upon subsequent equity issuances, subject to certain exceptions, provided that the Conversion Price shall not be adjusted to a price less than $2.23 per share, the closing price of our common stock on the Trading Market on the day immediately preceding the Closing Date. The Additional Investment is not subject to any conversion features. The obligations as disclosed above were unchanged. On May 13, 2026, we renegotiated the payment terms of the Debentures. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; On May 13, 2026, we entered into a second amendment agreement (the &#x201c;Second Amendment Agreement&#x201d;) to the JGB Purchase Agreement with each of the Purchasers and the Agent. The Second Amendment Agreement, among other things, extended the maturity date of the Debentures issued pursuant to the JGB Purchase Agreement by one year to April 15, 2028, revised the amortization schedule set forth in the Debentures and provided for a restructuring payment of $150 thousand payable on March 31, 2027 and an exit payment of $500 thousand payable on April 15, 2028. In connection with the Second Amendment Agreement, Mr. Lamendola granted a second lien mortgage on certain personal real property as additional collateral for the obligations under the Debentures. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;"&gt;Our obligations under the Debentures may be accelerated, at the Purchasers&#x2019; election or upon the occurrence of certain customary events of default. The Debentures contain customary representations, warranties and covenants including among other things and subject to certain exceptions, covenants that restrict us from incurring additional indebtedness, creating or permitting liens on assets, amending our charter documents and bylaws, repurchasing or otherwise acquiring more than a de minimis number of our common stock or equivalents thereof, repaying outstanding indebtedness, paying dividends or distributions, assigning or selling certain assets, making or holding any investments, and entering into transactions with affiliates.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;"&gt;The Company evaluated the Second Amendment Agreement under ASC 470-50, &#x201c;Debt - Modifications and Extinguishments&#x201d;, and determined that the amended terms were not substantially different from the terms of the existing Debentures. Accordingly, the Second Amendment Agreement was accounted for as a debt modification, and no gain or loss on extinguishment was recognized. The restructuring payment and exit payment were included in the revised contractual cash flows, and the related discounts are being amortized to interest expense using the effective interest method over the remaining term of the Debentures.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; As of June 30, 2026, the net carrying amount of the Debentures was $8.1 million, of which $2.0 million was short-term. The loan has unamortized debt premium, issuance costs, restructuring payment, and exit payment of $143 thousand, $110 thousand, $123 thousand and $458 thousand, respectively. The estimated fair value (Level 3) of the convertible debt instrument was $8.1 million as of June 30, 2026. During 2026, we made total principal payments of $800 thousand, while the interest of $591 thousand was paid as it was incurred. &lt;/p&gt;          &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;"&gt;Our future loan payments, which are presented as current portion of convertible debentures, net and convertible debentures, net of current portion on our accompanying unaudited condensed consolidated balance sheet as of June 30, 2026, are as follows:&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="font-weight: bold; border-bottom: Black 1.5pt solid;"&gt;June 30, 2026&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="width: 88%; text-align: left;"&gt;Convertible debenture principal&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;7,986&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left;"&gt;Restructuring and exit payment obligations&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;650&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: left; padding-bottom: 1.5pt;"&gt;Unamortized debt premium and issuance costs, net&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;(548&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left;"&gt;Outstanding balance, net&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;8,088&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: left; padding-bottom: 1.5pt;"&gt;Less: current portion, net&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;(1,966&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left; padding-bottom: 1.5pt;"&gt;Long-term portion, net&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;6,122&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:DebtInstrumentMaturityDate contextRef="cref_428381758" id="ixv-7482">2027-04-15</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentIssuedPrincipal
      contextRef="cref_428381758"
      decimals="-5"
      id="ixv-7483"
      unitRef="uref_388777331">11800000</us-gaap:DebtInstrumentIssuedPrincipal>
    <us-gaap:RedemptionPremium
      contextRef="cref_428381758"
      decimals="-6"
      id="ixv-7484"
      unitRef="uref_388777331">5000000</us-gaap:RedemptionPremium>
    <us-gaap:DebtInstrumentAnnualPrincipalPayment
      contextRef="cref_1422776500"
      decimals="-5"
      id="ixv-7485"
      unitRef="uref_388777331">6800000</us-gaap:DebtInstrumentAnnualPrincipalPayment>
    <us-gaap:InterestExpenseSubordinatedNotesAndDebentures
      contextRef="cref_428381758"
      decimals="-5"
      id="ixv-7486"
      unitRef="uref_388777331">6000000</us-gaap:InterestExpenseSubordinatedNotesAndDebentures>
    <mrai:AdditionalRedemptionPrice
      contextRef="cref_1030399269"
      decimals="-5"
      id="ixv-7487"
      unitRef="uref_388777331">5000000</mrai:AdditionalRedemptionPrice>
    <us-gaap:DebtInstrumentFeeAmount
      contextRef="cref_1312370311"
      decimals="-5"
      id="ixv-7488"
      unitRef="uref_388777331">5400000</us-gaap:DebtInstrumentFeeAmount>
    <mrai:PurchasePrice
      contextRef="cref_576166649"
      decimals="-6"
      id="ixv-7489"
      unitRef="uref_388777331">5000000</mrai:PurchasePrice>
    <us-gaap:InvestmentOwnedUnderlyingFaceAmountAtMarketValue
      contextRef="cref_1312370311"
      decimals="-5"
      id="ixv-7490"
      unitRef="uref_388777331">2000000</us-gaap:InvestmentOwnedUnderlyingFaceAmountAtMarketValue>
    <us-gaap:EscrowDeposit
      contextRef="cref_1312370311"
      decimals="-5"
      id="ixv-7491"
      unitRef="uref_388777331">3000000</us-gaap:EscrowDeposit>
    <us-gaap:InvestmentOwnedAtCost
      contextRef="cref_1828027660"
      decimals="-5"
      id="ixv-7492"
      unitRef="uref_388777331">3000000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:ShortTermDebtPercentageBearingFixedInterestRate
      contextRef="cref_2004002158"
      decimals="2"
      id="ixv-7493"
      unitRef="uref_2099918223">0.14</us-gaap:ShortTermDebtPercentageBearingFixedInterestRate>
    <us-gaap:DebtInstrumentAnnualPrincipalPayment
      contextRef="cref_1678445717"
      decimals="-3"
      id="ixv-7494"
      unitRef="uref_388777331">250000</us-gaap:DebtInstrumentAnnualPrincipalPayment>
    <us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent
      contextRef="cref_486616208"
      decimals="-5"
      id="ixv-7495"
      unitRef="uref_388777331">6800000</us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="cref_486616208"
      decimals="2"
      id="ixv-7496"
      unitRef="uref_1972424199">3</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="cref_1678445717"
      decimals="2"
      id="ixv-7497"
      unitRef="uref_1972424199">2.23</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <mrai:RestructuringPaymentPayable
      contextRef="cref_1303376523"
      decimals="-3"
      id="ixv-7498"
      unitRef="uref_388777331">150000</mrai:RestructuringPaymentPayable>
    <mrai:ExitPayment
      contextRef="cref_1624743679"
      decimals="-3"
      id="fc_1624743679"
      unitRef="uref_388777331">500000</mrai:ExitPayment>
    <us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent
      contextRef="cref_1678445717"
      decimals="-5"
      id="ixv-7500"
      unitRef="uref_388777331">8100000</us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent>
    <us-gaap:ShortTermBorrowings
      contextRef="cref_1678445717"
      decimals="-5"
      id="ixv-7501"
      unitRef="uref_388777331">2000000</us-gaap:ShortTermBorrowings>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet
      contextRef="cref_685214448"
      decimals="-3"
      id="ixv-7502"
      unitRef="uref_388777331">143000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="cref_685214448"
      decimals="-3"
      id="ixv-7503"
      unitRef="uref_388777331">110000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet
      contextRef="cref_1678445717"
      decimals="-3"
      id="ixv-7504"
      unitRef="uref_388777331">123000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="cref_1678445717"
      decimals="-3"
      id="ixv-7505"
      unitRef="uref_388777331">458000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DebtInstrumentFairValue
      contextRef="cref_335727296"
      decimals="-5"
      id="ixv-7506"
      unitRef="uref_388777331">8100000</us-gaap:DebtInstrumentFairValue>
    <mrai:PaymentForInterestAsIncurred
      contextRef="cref_61579801"
      decimals="-3"
      id="ixv-7507"
      unitRef="uref_388777331">800000</mrai:PaymentForInterestAsIncurred>
    <mrai:PaymentForInterestAsIncurred
      contextRef="cref_678316177"
      decimals="-3"
      id="ixv-7508"
      unitRef="uref_388777331">591000</mrai:PaymentForInterestAsIncurred>
    <us-gaap:ConvertibleDebtTableTextBlock contextRef="cref_678316177" id="ixv-3345">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;"&gt;Our future loan payments, which are presented as current portion of convertible debentures, net and convertible debentures, net of current portion on our accompanying unaudited condensed consolidated balance sheet as of June 30, 2026, are as follows:&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="font-weight: bold; border-bottom: Black 1.5pt solid;"&gt;June 30, 2026&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="width: 88%; text-align: left;"&gt;Convertible debenture principal&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;7,986&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left;"&gt;Restructuring and exit payment obligations&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;650&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: left; padding-bottom: 1.5pt;"&gt;Unamortized debt premium and issuance costs, net&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;(548&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left;"&gt;Outstanding balance, net&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;8,088&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: left; padding-bottom: 1.5pt;"&gt;Less: current portion, net&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;(1,966&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left; padding-bottom: 1.5pt;"&gt;Long-term portion, net&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;6,122&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:ConvertibleDebtTableTextBlock>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="cref_685214448"
      decimals="-3"
      id="ixv-7509"
      unitRef="uref_388777331">7986000</us-gaap:DebtInstrumentFaceAmount>
    <mrai:RestructuringAndExitPaymentObligations
      contextRef="cref_685214448"
      decimals="-3"
      id="ixv-7510"
      unitRef="uref_388777331">650000</mrai:RestructuringAndExitPaymentObligations>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="cref_685214448"
      decimals="-3"
      id="ixv-7511"
      unitRef="uref_388777331">-548000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:ConvertibleDebt
      contextRef="cref_685214448"
      decimals="-3"
      id="ixv-7512"
      unitRef="uref_388777331">8088000</us-gaap:ConvertibleDebt>
    <us-gaap:ConvertibleDebtCurrent
      contextRef="cref_685214448"
      decimals="-3"
      id="ixv-7513"
      unitRef="uref_388777331">1966000</us-gaap:ConvertibleDebtCurrent>
    <us-gaap:ConvertibleDebtNoncurrent
      contextRef="cref_685214448"
      decimals="-3"
      id="ixv-7514"
      unitRef="uref_388777331">6122000</us-gaap:ConvertibleDebtNoncurrent>
    <us-gaap:OtherLiabilitiesDisclosureTextBlock contextRef="cref_678316177" id="ixv-3392">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&lt;span style="font-weight: bold;"&gt;NOTE 8 &#x2013; OTHER LIABILITIES&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;Other liabilities consisted of the following:&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;(in thousands)&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center;"&gt;June 30,&lt;/td&gt; &lt;td style="font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center;"&gt;December 31,&lt;/td&gt; &lt;td style="font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;2026&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;2025&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="width: 76%; text-align: left;"&gt;Due to AXA (current and long-term)&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;20,732&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;19,401&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left; padding-bottom: 1.5pt;"&gt;Sublease security deposit&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;24&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;49&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: left; padding-bottom: 4pt;"&gt;Other liabilities&lt;/td&gt; &lt;td style="padding-bottom: 4pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;20,756&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 4pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;19,450&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;"&gt; As of June 30, 2026, we had $20.7 million in outstanding liabilities due to AXA in connection with our acquisition of Maestro Health on November 1, 2022. Included in the balance is accrued interest of $7.2 million and $5.2 million as of June 30, 2026 and December 31, 2025, respectively. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;"&gt;Our future payments to AXA, which are included in other short-term liabilities and other long-term liabilities on our accompanying unaudited condensed consolidated balance sheet as of June 30, 2026, are as follows:&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;(in thousands)&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="font-weight: bold; border-bottom: Black 1.5pt solid;"&gt;June 30, 2026&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="width: 88%; text-align: left;"&gt;Outstanding balance&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;20,732&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left; padding-bottom: 1.5pt;"&gt;Less: current portion&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;2,450&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: left; padding-bottom: 4pt;"&gt;Long-term portion&lt;/td&gt; &lt;td style="padding-bottom: 4pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;18,282&lt;/td&gt; &lt;td style="padding-bottom: 4pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;On July 16, 2026, we entered into Amendment No. 2 to Purchase Agreement (the &#x201c;AXA Amendment&#x201d;) with AXA. The AXA Amendment amends a Membership Interest Purchase Agreement, dated August 4, 2022, as amended on February 7, 2024 (the &#x201c;AXA Agreement&#x201d;), executed by and among the Company,&#160;XL America Inc., a Delaware corporation, Seaview Re Holdings Inc., a Delaware corporation and AXA, pursuant to which the Company acquired all the membership interests of Maestro Health, LLC.&#160;&lt;/p&gt; &lt;p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt; The AXA Amendment provides that the requirement by us to pay AXA an amount equal to thirty five percent of the net proceeds was amended such that from the date of the AXA Amendment through December 31, 2026, such payments will only be required after $5 million in offering proceeds are received by us. &lt;/p&gt; &lt;p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; The AXA Amendment also provides that the Company shall make minimum annual payments of not less than $0, $1.0 million, $5.0 million and approximately $22.3 million during the years ending December 31, 2026, 2027, 2028 and 2029, respectively. In addition, the Company agreed not to incur additional indebtedness other than its currently outstanding indebtedness. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; Subsequent to June 30, 2026, on July 29, 2026, we entered into a securities purchase agreement for the issuance and sale of 12,100 shares of newly designated Series A Preferred Stock for aggregate gross proceeds of $12.1 million. As a result of the Offering and pursuant to the terms of the AXA Amendment, approximately $2.45 million became payable to AXA based on the applicable net offering proceeds. Accordingly, approximately $2.45 million of the AXA liability is reflected as a current liability, with the remaining balance reflected as a non-current liability in the accompanying unaudited condensed consolidated balance sheet. &lt;/p&gt;          &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center;"&gt;&#160;&lt;/p&gt; &lt;p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt; On June 15, 2026, the Company entered into a second amendment to a certain client services agreement with a vendor. Under such amendment, the vendor paid an advance to the Company in the amount of $2.0 million against future contractual remittance amounts. The advance is recouped through amounts retained by the vendor during the 12-month period following the applicable implementation date. Any amount not recouped during that period is payable in cash, and the remaining unpaid balance becomes immediately due upon termination of the agreement. Past-due amounts bear a monthly charge of 1.5%. The Company recorded the proceeds as a vendor financing advance liability. The liability is reduced as applications against principal are confirmed through contractual invoices and reconciliations. As of June 30, 2026, the outstanding vendor financing advance was $2.0 million and was classified as a current liability within the accompanying unaudited condensed consolidated balance sheet. &lt;/p&gt;</us-gaap:OtherLiabilitiesDisclosureTextBlock>
    <us-gaap:OtherLiabilitiesTableTextBlock contextRef="cref_678316177" id="ixv-3396">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;Other liabilities consisted of the following:&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center;"&gt;June 30,&lt;/td&gt; &lt;td style="font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center;"&gt;December 31,&lt;/td&gt; &lt;td style="font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;2026&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;2025&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="width: 76%; text-align: left;"&gt;Due to AXA (current and long-term)&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;20,732&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;19,401&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left; padding-bottom: 1.5pt;"&gt;Sublease security deposit&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;24&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;49&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: left; padding-bottom: 4pt;"&gt;Other liabilities&lt;/td&gt; &lt;td style="padding-bottom: 4pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;20,756&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 4pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;19,450&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:OtherLiabilitiesTableTextBlock>
    <us-gaap:LongTermDebt
      contextRef="cref_685214448"
      decimals="-3"
      id="ixv-7515"
      unitRef="uref_388777331">20732000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="cref_560512737"
      decimals="-3"
      id="ixv-7516"
      unitRef="uref_388777331">19401000</us-gaap:LongTermDebt>
    <us-gaap:SecurityDepositLiability
      contextRef="cref_685214448"
      decimals="-3"
      id="ixv-7517"
      unitRef="uref_388777331">24000</us-gaap:SecurityDepositLiability>
    <us-gaap:SecurityDepositLiability
      contextRef="cref_560512737"
      decimals="-3"
      id="ixv-7518"
      unitRef="uref_388777331">49000</us-gaap:SecurityDepositLiability>
    <us-gaap:OtherLiabilities
      contextRef="cref_685214448"
      decimals="-3"
      id="ixv-7519"
      unitRef="uref_388777331">20756000</us-gaap:OtherLiabilities>
    <us-gaap:OtherLiabilities
      contextRef="cref_560512737"
      decimals="-3"
      id="ixv-7520"
      unitRef="uref_388777331">19450000</us-gaap:OtherLiabilities>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="cref_1249440349"
      decimals="-5"
      id="ixv-7521"
      unitRef="uref_388777331">20700000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrentAndNoncurrent
      contextRef="cref_685214448"
      decimals="-5"
      id="ixv-7522"
      unitRef="uref_388777331">7200000</us-gaap:OtherAccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrentAndNoncurrent
      contextRef="cref_560512737"
      decimals="-5"
      id="ixv-7523"
      unitRef="uref_388777331">5200000</us-gaap:OtherAccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:ScheduleOfDebtTableTextBlock contextRef="cref_678316177" id="ixv-3453">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;"&gt;Our future payments to AXA, which are included in other short-term liabilities and other long-term liabilities on our accompanying unaudited condensed consolidated balance sheet as of June 30, 2026, are as follows:&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="font-weight: bold; border-bottom: Black 1.5pt solid;"&gt;June 30, 2026&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="width: 88%; text-align: left;"&gt;Outstanding balance&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;20,732&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left; padding-bottom: 1.5pt;"&gt;Less: current portion&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;2,450&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: left; padding-bottom: 4pt;"&gt;Long-term portion&lt;/td&gt; &lt;td style="padding-bottom: 4pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;18,282&lt;/td&gt; &lt;td style="padding-bottom: 4pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:LongTermDebt
      contextRef="cref_685214448"
      decimals="-3"
      id="ixv-7524"
      unitRef="uref_388777331">20732000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebtCurrent
      contextRef="cref_685214448"
      decimals="-3"
      id="ixv-7525"
      unitRef="uref_388777331">2450000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="cref_685214448"
      decimals="-3"
      id="ixv-7526"
      unitRef="uref_388777331">18282000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="cref_1560543668"
      decimals="-6"
      id="ixv-7527"
      unitRef="uref_388777331">5000000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <mrai:OtherLiabilityAnnualPaymentDueReminderOfFiscalYear
      contextRef="cref_685214448"
      decimals="-6"
      id="ixv-7528"
      unitRef="uref_388777331">0</mrai:OtherLiabilityAnnualPaymentDueReminderOfFiscalYear>
    <mrai:OtherLiabilityAnnualPaymentDueNextTwelveMonths
      contextRef="cref_685214448"
      decimals="-5"
      id="ixv-7529"
      unitRef="uref_388777331">1000000</mrai:OtherLiabilityAnnualPaymentDueNextTwelveMonths>
    <mrai:OtherLiabilityAnnualPaymentDueYearTwo
      contextRef="cref_685214448"
      decimals="-5"
      id="ixv-7530"
      unitRef="uref_388777331">5000000</mrai:OtherLiabilityAnnualPaymentDueYearTwo>
    <mrai:OtherLiabilityAnnualPaymentDueYearThree
      contextRef="cref_685214448"
      decimals="-5"
      id="ixv-7531"
      unitRef="uref_388777331">22300000</mrai:OtherLiabilityAnnualPaymentDueYearThree>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="cref_2006171306"
      decimals="0"
      id="ixv-7532"
      unitRef="uref_917344505">12100</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
      contextRef="cref_2006171306"
      decimals="-5"
      id="ixv-7533"
      unitRef="uref_388777331">12100000</us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock>
    <mrai:NetOfferingProceeds
      contextRef="cref_2006171306"
      decimals="-4"
      id="ixv-7534"
      unitRef="uref_388777331">2450000</mrai:NetOfferingProceeds>
    <us-gaap:OtherLiabilities
      contextRef="cref_1277293661"
      decimals="-4"
      id="ixv-7535"
      unitRef="uref_388777331">2450000</us-gaap:OtherLiabilities>
    <mrai:VendorFinancingAdvance
      contextRef="cref_57105684"
      decimals="-5"
      id="ixv-7536"
      unitRef="uref_388777331">2000000</mrai:VendorFinancingAdvance>
    <mrai:PaidDueMonthlyChargePercentage
      contextRef="cref_922798872"
      decimals="3"
      id="fc_922798872"
      unitRef="uref_2099918223">0.015</mrai:PaidDueMonthlyChargePercentage>
    <mrai:VendorFinancingAdvance
      contextRef="cref_685214448"
      decimals="-5"
      id="ixv-7538"
      unitRef="uref_388777331">2000000</mrai:VendorFinancingAdvance>
    <us-gaap:RevenueFromContractWithCustomerTextBlock contextRef="cref_678316177" id="ixv-3507">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&lt;span style="font-weight: bold;"&gt;NOTE 9 &#x2013; REVENUE&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&lt;span style="font-weight: bold;"&gt;Disaggregation of Revenue&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;"&gt;The following tables illustrate the disaggregation of revenue by similar services:&lt;/span&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;For the six months ended:&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;(in thousands)&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;June 30,&lt;br/&gt; 2026&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;June 30,&lt;br/&gt; 2025&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="width: 76%; text-align: left;"&gt;TPA services&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;8,610&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;10,081&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left; padding-bottom: 1.5pt;"&gt;Captive insurance&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_898928874;"&gt;-&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;(7&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="padding-bottom: 4pt;"&gt;Total&lt;/td&gt; &lt;td style="padding-bottom: 4pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;8,610&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 4pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;10,074&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;For the three months ended:&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;(in thousands)&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;June 30,&lt;br/&gt; 2026&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;June 30,&lt;br/&gt; 2025&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="width: 76%; text-align: left;"&gt;TPA services&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;4,166&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;4,656&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left; padding-bottom: 1.5pt;"&gt;Captive insurance&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_201458801;"&gt;-&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_598184240;"&gt;-&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="padding-bottom: 4pt;"&gt;Total&lt;/td&gt; &lt;td style="padding-bottom: 4pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;4,166&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 4pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;4,656&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock contextRef="cref_678316177" id="ixv-3514">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;"&gt;The following tables illustrate the disaggregation of revenue by similar services:&lt;/span&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;June 30,&lt;br/&gt; 2026&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;June 30,&lt;br/&gt; 2025&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="width: 76%; text-align: left;"&gt;TPA services&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;8,610&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;10,081&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left; padding-bottom: 1.5pt;"&gt;Captive insurance&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_898928874;"&gt;-&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;(7&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="padding-bottom: 4pt;"&gt;Total&lt;/td&gt; &lt;td style="padding-bottom: 4pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;8,610&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 4pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;10,074&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;June 30,&lt;br/&gt; 2026&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;June 30,&lt;br/&gt; 2025&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="width: 76%; text-align: left;"&gt;TPA services&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;4,166&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;4,656&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left; padding-bottom: 1.5pt;"&gt;Captive insurance&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_201458801;"&gt;-&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_598184240;"&gt;-&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="padding-bottom: 4pt;"&gt;Total&lt;/td&gt; &lt;td style="padding-bottom: 4pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;4,166&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 4pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;4,656&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="cref_1261990852"
      decimals="-3"
      id="ixv-7539"
      unitRef="uref_388777331">8610000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="cref_1074043652"
      decimals="-3"
      id="ixv-7540"
      unitRef="uref_388777331">10081000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="cref_267200198"
      decimals="-3"
      id="ixv-7541"
      unitRef="uref_388777331">-7000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="cref_678316177"
      decimals="-3"
      id="ixv-7542"
      unitRef="uref_388777331">8610000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="cref_968639710"
      decimals="-3"
      id="ixv-7543"
      unitRef="uref_388777331">10074000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="cref_1346636084"
      decimals="-3"
      id="ixv-7544"
      unitRef="uref_388777331">4166000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="cref_735862645"
      decimals="-3"
      id="ixv-7545"
      unitRef="uref_388777331">4656000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="cref_1864859878"
      decimals="-3"
      id="ixv-7546"
      unitRef="uref_388777331">4166000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="cref_696692331"
      decimals="-3"
      id="ixv-7547"
      unitRef="uref_388777331">4656000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="cref_678316177" id="ixv-3628">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&lt;span style="font-weight: bold;"&gt;NOTE 10 &#x2013; SHARE-BASED COMPENSATION&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&lt;span style="font-weight: bold;"&gt;Global Stock Incentive Plan&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;"&gt; On May 31, 2023, our shareholders approved our board of directors (the &#x201c;Board&#x201d;) proposal to increase our 2020 Global Incentive Plan (the &#x201c;2020 Plan&#x201d;) by an additional 500,000 shares, thus bringing the total number of stock options, restricted stock units (&#x201c;RSUs&#x201d;) and restricted stock awards (&#x201c;RSAs&#x201d;) that may be issued pursuant to the 2020 Plan to 2,450,855. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;"&gt; Under the terms of the 2020 Plan, on the grant date, the Board determines the vesting schedule of each stock option and RSU on an individual basis. All stock options expire ten (10) years from the date of the grant. Vested options expire 90 days after the termination of employment of the grantee. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; On May 6, 2024, our shareholders approved our 2024 Global Incentive Plan (the &#x201c;2024 Plan&#x201d;), under which 2,227,910 shares of common stock were initially reserved for issuance. The 2024 Plan includes an evergreen provision pursuant to which the number of shares reserved for issuance automatically resets to 2,227,910 on January 1st of each year. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&#160;&lt;/p&gt; &lt;p style="text-align: justify; margin: 0pt 0; font: 10pt Times New Roman, Times, Serif;"&gt; Under the terms of the 2024 Plan, on the grant date, the Board determines the vesting schedule of each stock option and RSUs on an individual basis. All stock options expire ten (10) years from the date of the grant. Vested options expire 90 days after the termination of employment of the grantee. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&lt;span style="font-weight: bold;"&gt;Stock Options&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;There were no options granted for the six months ended June 30, 2026 and 2025.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;The following table summarizes the stock option activity for the six months ended June 30, 2026:&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;(in thousands except share and per share data)&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Number of&lt;br/&gt; Options&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Weighted&lt;br/&gt; Average&lt;br/&gt; Exercise&lt;br/&gt; Price&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Weighted&lt;br/&gt; Average&lt;br/&gt; Remaining&lt;br/&gt; Term&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Aggregate&lt;br/&gt; Intrinsic&lt;br/&gt; Value&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="width: 52%;"&gt;Balance at January 1, 2026&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;738,500&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;2.07&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;5.36&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_683036858;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td&gt;Granted&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_875834485;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_2089508952;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td&gt;Forfeited/Cancelled&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;(13,000&lt;/td&gt; &lt;td style="text-align: left;"&gt;)&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;2.23&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;Exercised&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_613335784;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_767358761;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="padding-bottom: 4pt;"&gt;Balance at June 30, 2026&lt;/td&gt; &lt;td style="padding-bottom: 4pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;725,500&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 4pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;2.07&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 4pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;4.82&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 4pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1824740326;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;Exercisable at June 30, 2026&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;693,417&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;2.08&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;4.71&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1728476536;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;           &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;The following table summarizes our non-vested stock options:&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Non-vested&lt;br/&gt; Options&lt;br/&gt; Outstanding&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Weighted-&lt;br/&gt; Average&lt;br/&gt; Grant Date&lt;br/&gt; Fair Value&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="width: 76%;"&gt;Balance at January 1, 2026&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;57,943&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;1.59&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left;"&gt;Options granted&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_708546188;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1100784233;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: left;"&gt;Options forfeited/cancelled&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;(3,958&lt;/td&gt; &lt;td style="text-align: left;"&gt;)&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;1.58&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left;"&gt;Options exercised&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_970156303;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1957172883;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: left; padding-bottom: 1.5pt;"&gt;Options vested&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;(21,902&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;)&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;1.60&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="padding-bottom: 4pt;"&gt;Balance at June 30, 2026&lt;/td&gt; &lt;td style="padding-bottom: 4pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;32,083&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 4pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;1.59&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; For the three months ended June 30, 2026 and 2025, we recognized $14 thousand and $33 thousand of stock compensation expense relating to stock options, respectively. For the six months ended June 30, 2026 and 2025, we recognized $32 thousand and $79 thousand of stock compensation expense relating to stock options, respectively. As of June 30, 2026, there was $51 thousand of unrecognized stock compensation expense related to non-vested share-based compensation arrangements granted under the Plan. That cost is expected to be recognized over a weighted-average period of approximately 1.2 years. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&lt;span style="font-weight: bold;"&gt;Restricted Stock Units&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;"&gt; On January 28, 2025, the compensation committee of the Board granted a director restricted stock unit (&#x201c;&lt;span style="text-decoration:underline"&gt;RSU&lt;/span&gt;&#x201d;) award pursuant to which the holder has the right to receive an aggregate of 600,000 shares of our common stock in connection with the holder being a personal guarantor on new financing. These awards were granted outside of a company global stock incentive plan and vest as follows: 200,000 RSUs vested upon grant, and 400,000 RSUs vest on the first and second-year anniversaries of the date of grant. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;"&gt; On March 7, 2025, the compensation committee of the Board granted various employees RSU awards, under which the holders have the right to receive an aggregate of 82,000 shares of our common stock. These awards vested on the date of grant. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; On February 2, 2026, the compensation committee of the board of directors granted certain employees RSU awards, under which the holder has the right to receive an aggregate of&#160;50,000 shares of common stock. These awards will vest over the next 2 years. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; On February 2, 2026, we issued&#160;31,746&#160;shares of common stock to a vendor in consideration for services rendered. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; On February 2, 2026, we issued&#160;20,000&#160;shares of common stock to a vendor in consideration for services rendered. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; On March 5, 2026, we granted an RSU award to a board member under which the holder has the right to receive an aggregate of 300,000 shares of common stock for services related to the strategic transaction initiative. During the three months ended June 30, 2026, 200,000 of these shares were cancelled. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;"&gt; On March 13, 2026, the compensation committee of the board of directors granted various employees inducement RSU awards, under which the holders have the right to receive an aggregate of&#160;424,799&#160;shares of common stock. These awards vested on the date of grant. These RSU awards were issued to settle 2025 bonuses to employees and accordingly the Company recorded $211 thousand of expense during the year ended December 31, 2025. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;On March 13, 2026, we issued&#160;6,345&#160;shares of common stock to a vendor in consideration for services rendered.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; On April 16, 2026, the compensation committee of the board of directors granted certain employees RSU awards, under which the holder has the right to receive an aggregate of&#160;37,500 shares of common stock. These awards will vest over the next 2 years. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; On April 16, 2026, we granted&#160;45,000&#160;shares of common stock to vendors in consideration for services rendered. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; On May 21, 2026, we granted an RSU award to a board member under which the holder has the right to receive an aggregate of 166,667 shares of common stock for services related to the strategic transaction initiative. This award vested upon grant. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="text-align: justify; margin: 0pt 0; font: 10pt Times New Roman, Times, Serif;"&gt; On May 29, 2026, the compensation committee of the board of directors granted certain board members and executives RSU awards, under which the holders have the right to receive an aggregate of up to&#160;1,050,000&#160;shares of our common stock. These awards vested on the date of grant. &lt;/p&gt;          &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;The following table summarizes the restricted stock units activity for the six months ended June 30, 2026:&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid;"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center;"&gt;&lt;span style="font-weight: bold;"&gt;Restricted&lt;br/&gt; Stock&lt;br/&gt; Units&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid;"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center;"&gt;&lt;span style="font-weight: bold;"&gt;Weighted-&lt;br/&gt; Average&lt;br/&gt; Grant Date&lt;br/&gt; Fair Value&lt;br/&gt; Per Share&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="width: 76%;"&gt;Outstanding at January 1, 2026&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;1,620,500&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;1.60&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td&gt;Granted&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;2,132,057&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;0.59&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td&gt;Forfeited/cancelled&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;(600,000&lt;/td&gt; &lt;td style="text-align: left;"&gt;)&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;1.31&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;Vested&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;(2,490,057&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;)&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;0.92&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="padding-bottom: 4pt;"&gt;Outstanding at June 30, 2026&lt;/td&gt; &lt;td style="padding-bottom: 4pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;662,500&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 4pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;0.97&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; For the three months ended June 30, 2026 and 2025, the Company recognized $923 thousand and $436 thousand of stock compensation expense relating to RSUs, respectively. For the six months ended June 30, 2026 and 2025, the Company recognized $1.1 million and $964 thousand of stock compensation expense relating to RSUs, respectively. As of June 30, 2026, there was $261 thousand of unrecognized compensation expense remaining related to unvested time-vested RSUs. That cost is expected to be recognized over a weighted-average period of approximately 0.5 years. &lt;/p&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="cref_2077819978"
      decimals="INF"
      id="ixv-7548"
      unitRef="uref_917344505">500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="cref_799465022"
      decimals="INF"
      id="ixv-7549"
      unitRef="uref_917344505">2450855</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod contextRef="cref_539106327" id="ixv-7550">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <mrai:TerminationTermAfterTerminationOfEmploymentOfGrantee contextRef="cref_539106327" id="ixv-7551">P90D</mrai:TerminationTermAfterTerminationOfEmploymentOfGrantee>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="cref_299327299"
      decimals="0"
      id="ixv-7552"
      unitRef="uref_917344505">2227910</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="cref_299327299"
      decimals="0"
      id="fc_299327299"
      unitRef="uref_917344505">2227910</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod contextRef="cref_1448377746" id="ixv-7554">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <mrai:TerminationTermAfterTerminationOfEmploymentOfGrantee contextRef="cref_1448377746" id="ixv-7555">P90D</mrai:TerminationTermAfterTerminationOfEmploymentOfGrantee>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="cref_678316177" id="ixv-3648">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;The following table summarizes the stock option activity for the six months ended June 30, 2026:&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Number of&lt;br/&gt; Options&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Weighted&lt;br/&gt; Average&lt;br/&gt; Exercise&lt;br/&gt; Price&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Weighted&lt;br/&gt; Average&lt;br/&gt; Remaining&lt;br/&gt; Term&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Aggregate&lt;br/&gt; Intrinsic&lt;br/&gt; Value&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="width: 52%;"&gt;Balance at January 1, 2026&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;738,500&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;2.07&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;5.36&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_683036858;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td&gt;Granted&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_875834485;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_2089508952;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td&gt;Forfeited/Cancelled&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;(13,000&lt;/td&gt; &lt;td style="text-align: left;"&gt;)&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;2.23&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;Exercised&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_613335784;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_767358761;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="padding-bottom: 4pt;"&gt;Balance at June 30, 2026&lt;/td&gt; &lt;td style="padding-bottom: 4pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;725,500&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 4pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;2.07&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 4pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;4.82&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 4pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1824740326;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;Exercisable at June 30, 2026&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;693,417&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;2.08&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;4.71&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1728476536;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="cref_560512737"
      decimals="INF"
      id="ixv-7556"
      unitRef="uref_917344505">738500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="cref_560512737"
      decimals="2"
      id="ixv-7557"
      unitRef="uref_1972424199">2.07</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="cref_1398839902" id="ixv-7558">P5Y4M9D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="cref_678316177"
      decimals="INF"
      id="ixv-7559"
      unitRef="uref_917344505">13000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="cref_678316177"
      decimals="2"
      id="ixv-7560"
      unitRef="uref_1972424199">2.23</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="cref_685214448"
      decimals="INF"
      id="ixv-7561"
      unitRef="uref_917344505">725500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="cref_685214448"
      decimals="2"
      id="ixv-7562"
      unitRef="uref_1972424199">2.07</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="cref_678316177" id="ixv-7563">P4Y9M25D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="cref_685214448"
      decimals="INF"
      id="ixv-7564"
      unitRef="uref_917344505">693417</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="cref_685214448"
      decimals="2"
      id="ixv-7565"
      unitRef="uref_1972424199">2.08</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="cref_678316177" id="ixv-7566">P4Y8M15D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock contextRef="cref_678316177" id="ixv-3807">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;The following table summarizes our non-vested stock options:&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Non-vested&lt;br/&gt; Options&lt;br/&gt; Outstanding&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Weighted-&lt;br/&gt; Average&lt;br/&gt; Grant Date&lt;br/&gt; Fair Value&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="width: 76%;"&gt;Balance at January 1, 2026&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;57,943&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;1.59&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left;"&gt;Options granted&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_708546188;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1100784233;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: left;"&gt;Options forfeited/cancelled&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;(3,958&lt;/td&gt; &lt;td style="text-align: left;"&gt;)&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;1.58&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left;"&gt;Options exercised&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_970156303;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1957172883;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: left; padding-bottom: 1.5pt;"&gt;Options vested&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;(21,902&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;)&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;1.60&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="padding-bottom: 4pt;"&gt;Balance at June 30, 2026&lt;/td&gt; &lt;td style="padding-bottom: 4pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;32,083&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 4pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;1.59&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
      contextRef="cref_560512737"
      decimals="INF"
      id="ixv-7567"
      unitRef="uref_917344505">57943</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="cref_560512737"
      decimals="2"
      id="ixv-7568"
      unitRef="uref_1972424199">1.59</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
      contextRef="cref_678316177"
      decimals="INF"
      id="ixv-7569"
      unitRef="uref_917344505">3958</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
      contextRef="cref_678316177"
      decimals="2"
      id="ixv-7570"
      unitRef="uref_1972424199">1.58</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
      contextRef="cref_678316177"
      decimals="INF"
      id="ixv-7571"
      unitRef="uref_917344505">21902</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
      contextRef="cref_678316177"
      decimals="2"
      id="ixv-7572"
      unitRef="uref_1972424199">1.6</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
      contextRef="cref_685214448"
      decimals="INF"
      id="ixv-7573"
      unitRef="uref_917344505">32083</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="cref_685214448"
      decimals="2"
      id="ixv-7574"
      unitRef="uref_1972424199">1.59</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="cref_1299040678"
      decimals="-3"
      id="ixv-7575"
      unitRef="uref_388777331">14000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="cref_1372569509"
      decimals="-3"
      id="ixv-7576"
      unitRef="uref_388777331">33000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="cref_1743034571"
      decimals="-3"
      id="ixv-7577"
      unitRef="uref_388777331">32000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="cref_308193255"
      decimals="-3"
      id="ixv-7578"
      unitRef="uref_388777331">79000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="cref_408305594"
      decimals="-3"
      id="ixv-7579"
      unitRef="uref_388777331">51000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="cref_1743034571" id="ixv-7580">P1Y2M12D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="cref_1098369590"
      decimals="0"
      id="fc_1098369590"
      unitRef="uref_917344505">600000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="cref_717754146"
      decimals="0"
      id="ixv-7582"
      unitRef="uref_917344505">200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="cref_1787917770"
      decimals="0"
      id="ixv-7583"
      unitRef="uref_917344505">400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="cref_87961422"
      decimals="0"
      id="fc_87961422"
      unitRef="uref_917344505">82000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="cref_2125158039"
      decimals="0"
      id="fc_2125158039"
      unitRef="uref_917344505">50000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="cref_1170613260"
      decimals="0"
      id="ixv-7586"
      unitRef="uref_917344505">31746</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="cref_1149706590"
      decimals="0"
      id="ixv-7587"
      unitRef="uref_917344505">20000</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="cref_1202730097"
      decimals="0"
      id="fc_1202730097"
      unitRef="uref_917344505">300000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="cref_1387594773"
      decimals="0"
      id="ixv-7589"
      unitRef="uref_917344505">200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="cref_1752949693"
      decimals="0"
      id="fc_1752949693"
      unitRef="uref_917344505">424799</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:AccruedBonusesCurrentAndNoncurrent
      contextRef="cref_560512737"
      decimals="-3"
      id="ixv-7591"
      unitRef="uref_388777331">211000</us-gaap:AccruedBonusesCurrentAndNoncurrent>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="cref_1796326046"
      decimals="0"
      id="fc_1796326046"
      unitRef="uref_917344505">37500</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="cref_523754851"
      decimals="0"
      id="fc_523754851"
      unitRef="uref_917344505">45000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="cref_1381851302"
      decimals="0"
      id="fc_1381851302"
      unitRef="uref_917344505">166667</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="cref_1099064921"
      decimals="0"
      id="fc_1099064921"
      unitRef="uref_917344505">1050000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock contextRef="cref_678316177" id="ixv-3932">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;The following table summarizes the restricted stock units activity for the six months ended June 30, 2026:&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid;"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center;"&gt;&lt;span style="font-weight: bold;"&gt;Restricted&lt;br/&gt; Stock&lt;br/&gt; Units&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid;"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center;"&gt;&lt;span style="font-weight: bold;"&gt;Weighted-&lt;br/&gt; Average&lt;br/&gt; Grant Date&lt;br/&gt; Fair Value&lt;br/&gt; Per Share&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="width: 76%;"&gt;Outstanding at January 1, 2026&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;1,620,500&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;1.60&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td&gt;Granted&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;2,132,057&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;0.59&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td&gt;Forfeited/cancelled&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;(600,000&lt;/td&gt; &lt;td style="text-align: left;"&gt;)&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;1.31&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;Vested&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;(2,490,057&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;)&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;0.92&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="padding-bottom: 4pt;"&gt;Outstanding at June 30, 2026&lt;/td&gt; &lt;td style="padding-bottom: 4pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;662,500&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 4pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;0.97&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="cref_1688485009"
      decimals="INF"
      id="ixv-7596"
      unitRef="uref_917344505">1620500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="cref_1688485009"
      decimals="2"
      id="ixv-7597"
      unitRef="uref_1972424199">1.6</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <mrai:ShareBasedCompensationsArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="cref_56077519"
      decimals="INF"
      id="fc_1155957666"
      unitRef="uref_917344505">2132057</mrai:ShareBasedCompensationsArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="cref_56077519"
      decimals="2"
      id="ixv-7599"
      unitRef="uref_1972424199">0.59</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="cref_56077519"
      decimals="INF"
      id="ixv-7600"
      unitRef="uref_917344505">600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="cref_56077519"
      decimals="2"
      id="ixv-7601"
      unitRef="uref_1972424199">1.31</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="cref_56077519"
      decimals="INF"
      id="ixv-7602"
      unitRef="uref_917344505">2490057</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="cref_56077519"
      decimals="2"
      id="ixv-7603"
      unitRef="uref_1972424199">0.92</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="cref_1518419059"
      decimals="INF"
      id="ixv-7604"
      unitRef="uref_917344505">662500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="cref_1518419059"
      decimals="2"
      id="ixv-7605"
      unitRef="uref_1972424199">0.97</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="cref_981354773"
      decimals="-3"
      id="ixv-7606"
      unitRef="uref_388777331">923000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="cref_403226097"
      decimals="-3"
      id="ixv-7607"
      unitRef="uref_388777331">436000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="cref_678316177"
      decimals="-5"
      id="ixv-7608"
      unitRef="uref_388777331">1100000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="cref_968639710"
      decimals="-3"
      id="ixv-7609"
      unitRef="uref_388777331">964000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="cref_1518419059"
      decimals="-3"
      id="ixv-7610"
      unitRef="uref_388777331">261000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="cref_56077519" id="ixv-7611">P0Y6M</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <mrai:WarrantsAndRightsNoteDisclosureTextBlock contextRef="cref_678316177" id="ixv-4008">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&lt;span style="font-weight: bold;"&gt;NOTE 11 &#x2013; WARRANTS&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;We have issued warrants as part of equity offerings and severance packages.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;The table below summarizes our warrant activities:&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Number of &lt;br/&gt; Warrants to &lt;br/&gt; Purchase&lt;br/&gt; Common&lt;br/&gt; Shares&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Exercise &lt;br/&gt; Price&lt;br/&gt; Range&lt;br/&gt; Per Share&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Weighted&lt;br/&gt; Average&lt;br/&gt; Exercise&lt;br/&gt; Price&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="width: 61%;"&gt;Balance at January 1, 2026&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;8,953,602&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 12%; text-align: right;"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;"&gt; 1.00 to 31.60&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;2.06&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td&gt;Granted&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1058397457;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1677790641;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_2088495238;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td&gt;Forfeited&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;(242,977&lt;/td&gt; &lt;td style="text-align: left;"&gt;)&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;31.60&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;31.60&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;Exercised&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_950521858;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1993400703;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1184182678;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="padding-bottom: 4pt;"&gt;Balance at June 30, 2026&lt;/td&gt; &lt;td style="padding-bottom: 4pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;8,710,625&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 4pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;"&gt; 1.00 to 20.00&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 4pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;1.24&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td&gt;Balance at January 1, 2025&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;644,718&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;"&gt;$ 2.50 to 31.60&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;$&lt;/td&gt; &lt;td style="text-align: right;"&gt;16.40&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td&gt;Granted&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1114912567;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_241447946;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1600341133;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td&gt;Forfeited&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;(91,117&lt;/td&gt; &lt;td style="text-align: left;"&gt;)&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;5.71&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;5.71&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;Exercised&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_788704778;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_875979209;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1057347459;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="padding-bottom: 4pt;"&gt;Balance at June 30, 2025&lt;/td&gt; &lt;td style="padding-bottom: 4pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;553,601&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 4pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;"&gt; 2.50 to 31.60&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 4pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;18.16&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</mrai:WarrantsAndRightsNoteDisclosureTextBlock>
    <us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock contextRef="cref_678316177" id="ixv-4014">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;The table below summarizes our warrant activities:&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Number of &lt;br/&gt; Warrants to &lt;br/&gt; Purchase&lt;br/&gt; Common&lt;br/&gt; Shares&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Exercise &lt;br/&gt; Price&lt;br/&gt; Range&lt;br/&gt; Per Share&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Weighted&lt;br/&gt; Average&lt;br/&gt; Exercise&lt;br/&gt; Price&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="width: 61%;"&gt;Balance at January 1, 2026&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;8,953,602&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 12%; text-align: right;"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;"&gt; 1.00 to 31.60&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;2.06&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td&gt;Granted&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1058397457;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1677790641;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_2088495238;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td&gt;Forfeited&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;(242,977&lt;/td&gt; &lt;td style="text-align: left;"&gt;)&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;31.60&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;31.60&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;Exercised&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_950521858;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1993400703;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1184182678;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="padding-bottom: 4pt;"&gt;Balance at June 30, 2026&lt;/td&gt; &lt;td style="padding-bottom: 4pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;8,710,625&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 4pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;"&gt; 1.00 to 20.00&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 4pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;1.24&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td&gt;Balance at January 1, 2025&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;644,718&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;"&gt;$ 2.50 to 31.60&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;$&lt;/td&gt; &lt;td style="text-align: right;"&gt;16.40&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td&gt;Granted&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1114912567;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_241447946;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1600341133;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td&gt;Forfeited&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;(91,117&lt;/td&gt; &lt;td style="text-align: left;"&gt;)&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;5.71&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;5.71&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;Exercised&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_788704778;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_875979209;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1057347459;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="padding-bottom: 4pt;"&gt;Balance at June 30, 2025&lt;/td&gt; &lt;td style="padding-bottom: 4pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;553,601&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 4pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;"&gt; 2.50 to 31.60&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 4pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;18.16&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="cref_684365930"
      decimals="INF"
      id="ixv-7612"
      unitRef="uref_917344505">8953602</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <mrai:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRange
      contextRef="cref_1610511180"
      decimals="2"
      id="ixv-7613"
      unitRef="uref_1972424199">1</mrai:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRange>
    <mrai:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRange
      contextRef="cref_1680470473"
      decimals="2"
      id="ixv-7614"
      unitRef="uref_1972424199">31.6</mrai:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRange>
    <mrai:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePrice
      contextRef="cref_684365930"
      decimals="2"
      id="ixv-7615"
      unitRef="uref_1972424199">2.06</mrai:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures
      contextRef="cref_1887911658"
      decimals="INF"
      id="ixv-7616"
      unitRef="uref_917344505">242977</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures>
    <mrai:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeForfeited
      contextRef="cref_1887911658"
      decimals="2"
      id="ixv-7617"
      unitRef="uref_1972424199">31.6</mrai:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeForfeited>
    <mrai:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceForfeited
      contextRef="cref_1887911658"
      decimals="2"
      id="ixv-7618"
      unitRef="uref_1972424199">31.6</mrai:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceForfeited>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="cref_1050108937"
      decimals="INF"
      id="ixv-7619"
      unitRef="uref_917344505">8710625</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <mrai:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRange
      contextRef="cref_877497746"
      decimals="2"
      id="ixv-7620"
      unitRef="uref_1972424199">1</mrai:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRange>
    <mrai:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRange
      contextRef="cref_1247677442"
      decimals="2"
      id="ixv-7621"
      unitRef="uref_1972424199">20</mrai:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRange>
    <mrai:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePrice
      contextRef="cref_1050108937"
      decimals="2"
      id="ixv-7622"
      unitRef="uref_1972424199">1.24</mrai:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="cref_1516893171"
      decimals="INF"
      id="ixv-7623"
      unitRef="uref_917344505">644718</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <mrai:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRange
      contextRef="cref_1447836475"
      decimals="2"
      id="ixv-7624"
      unitRef="uref_1972424199">2.5</mrai:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRange>
    <mrai:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRange
      contextRef="cref_1585372191"
      decimals="2"
      id="ixv-7625"
      unitRef="uref_1972424199">31.6</mrai:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRange>
    <mrai:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePrice
      contextRef="cref_1516893171"
      decimals="2"
      id="ixv-7626"
      unitRef="uref_1972424199">16.4</mrai:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures
      contextRef="cref_923970876"
      decimals="INF"
      id="ixv-7627"
      unitRef="uref_917344505">91117</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures>
    <mrai:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeForfeited
      contextRef="cref_923970876"
      decimals="2"
      id="ixv-7628"
      unitRef="uref_1972424199">5.71</mrai:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeForfeited>
    <mrai:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceForfeited
      contextRef="cref_923970876"
      decimals="2"
      id="ixv-7629"
      unitRef="uref_1972424199">5.71</mrai:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceForfeited>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="cref_1972424199"
      decimals="INF"
      id="ixv-7630"
      unitRef="uref_917344505">553601</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <mrai:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRange
      contextRef="cref_429591522"
      decimals="2"
      id="ixv-7631"
      unitRef="uref_1972424199">2.5</mrai:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRange>
    <mrai:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRange
      contextRef="cref_757566738"
      decimals="2"
      id="ixv-7632"
      unitRef="uref_1972424199">31.6</mrai:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRange>
    <mrai:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePrice
      contextRef="cref_1972424199"
      decimals="2"
      id="ixv-7633"
      unitRef="uref_1972424199">18.16</mrai:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePrice>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="cref_678316177" id="ixv-4211">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&lt;span style="font-weight: bold;"&gt;NOTE 12 &#x2013; SEGMENT INFORMATION&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;Research and development activities were conducted through our wholly owned subsidiary, EYME Technologies, Ltd., in Israel. Geographic long-lived asset information presented below is based on the physical location of the assets at the reporting date. All of our revenues are derived from customers located in the United States.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;"&gt;All of our long-lived assets including capitalized software, and operating lease right of use assets are located in the United States.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;"&gt; The Company operates as one operating segment. Our consolidated results represent the results of our one operating segment based on how our Chief Operating Decision Maker (&#x201c;CODM&#x201d;), our &lt;span style="-sec-ix-hidden:fc_309145295;"&gt;Chief Executive Officer&lt;/span&gt;, views the business for purposes of evaluating financial performance, allocating resources, and making overall operating decisions. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;"&gt;The CODM reviews financial information on a consolidated basis and uses the segment performance measure of consolidated net loss to measure segment profit or loss. The accounting policies of our single reportable segment are the same as those for the consolidated financial statements. The level of disaggregation and amounts of significant segment expenses that are regularly provided to the CODM are the same as those presented in the consolidated statement of operations. Likewise, the measure of segment assets is reported on the consolidated balance sheets as total assets. The CODM does not regularly review asset information and therefore, we do not report asset information beyond what is presented in the consolidated balance sheets.&lt;/p&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="cref_678316177"
      decimals="0"
      id="ixv-7634"
      unitRef="uref_1231523903">1</us-gaap:NumberOfOperatingSegments>
    <us-gaap:SegmentReportingCodmProfitLossMeasureHowUsedDescription contextRef="cref_678316177" id="ixv-4220">Our consolidated results represent the results of our one operating segment based on how our Chief Operating Decision Maker (&#x201c;CODM&#x201d;), our Chief Executive Officer, views the business for purposes of evaluating financial performance, allocating resources, and making overall operating decisions.</us-gaap:SegmentReportingCodmProfitLossMeasureHowUsedDescription>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="cref_678316177" id="ixv-4236">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&lt;span style="font-weight: bold;"&gt;NOTE 13 &#x2013; RELATED PARTY TRANSACTIONS&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;"&gt; On February 12, 2026, the Company issued a promissory note (&#x201c;Note 1&#x201d;) in the principal amount of $410 thousand to the Company&#x2019;s Chief Executive Officer (the &#x201c;Holder&#x201d;). Note 1 accrues interest at a rate of 12.0% per annum (or the maximum amount of interest allowed under the laws of the State of New York, whichever is less) until Note 1 is repaid in full. Note 1 may be prepaid by the Company, in whole or in part, together with all interest then accrued and any other sums then due and payable to the Holder, at any time, without premium or penalty. All payments of outstanding principal, interest and all other amounts due under Note 1 are payable by April 11, 2026 to the Holder, or its successors and assigns. The proceeds of Note 1 will be used by the Company for general working capital purposes. On April 29, 2026, we entered into an amendment agreement with the Holder pursuant to which the maturity date of Note 1 was extended to September 1, 2026. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;"&gt; On March 9, 2026, the Company issued a promissory note (&#x201c;Note 2&#x201d;) in the principal amount of $250 thousand to the Company&#x2019;s Chief Executive Officer. Note 2 accrues interest at a rate of 12.0% per annum (or the maximum amount of interest allowed under the laws of the State of New York, whichever is less) until Note 2 is repaid in full. Note 2 may be prepaid by the Company, in whole or in part, together with all interest then accrued and any other sums then due and payable to the Holder, at any time, without premium or penalty. All payments of outstanding principal, interest and all other amounts due under Note 2 are payable by May 10, 2026 to the Holder, or its successors and assigns. The proceeds of Note 2 will be used by the Company for general working capital purposes. On April 29, 2026, we entered into an amendment agreement with the Holder pursuant to which the maturity date of Note 2 was extended to September 1, 2026. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;"&gt;On June 22, 2026, the Company satisfied all outstanding principal balances related to Note 1 and Note 2 through full repayment to the related party.&lt;/span&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;"&gt; In connection with Note 1 and Note 2, accrued interest of $26 thousand is included within due to related party within the accompanying condensed consolidated balance sheets. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;"&gt; For the three and six months ended June 30, 2026, we recorded interest expense of $18 thousand and $26 thousand related to Note 1 and Note 2, respectively. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The Company provides third-party administrator services to an entity whose chief executive officer also serves as the Company&#x2019;s Head of Sales. Financial arrangements with the related party are subject to approval by the Company&#x2019;s Board and Chief Financial Officer.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; On April 29, 2026, the Company received a $500 thousand advance payment from the related party for future third-party administrator services. The Company recognized $183 thousand of related-party revenue during each of the three and six months ended June 30, 2026. As of June 30, 2026, the remaining $317 thousand was included in deferred revenue in the accompanying unaudited condensed consolidated balance sheet. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="text-align: justify; margin: 0pt 0; font: 10pt Times New Roman, Times, Serif;"&gt; On May 13, 2026, the Company received an additional refundable cash advance of $1.0 million from the related party. No revenue was recognized in connection with this advance, and the full amount was included in due to related party in the accompanying unaudited condensed consolidated balance sheet as of June 30, 2026. On July 9, 2026, the Company repaid the $1.0 million advance in full. &lt;/p&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="cref_1994068421"
      decimals="-3"
      id="ixv-7635"
      unitRef="uref_388777331">410000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionRate
      contextRef="cref_1994068421"
      decimals="3"
      id="ixv-7636"
      unitRef="uref_2099918223">0.12</us-gaap:RelatedPartyTransactionRate>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="cref_1920807326"
      decimals="-3"
      id="ixv-7637"
      unitRef="uref_388777331">250000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionRate
      contextRef="cref_1920807326"
      decimals="3"
      id="ixv-7638"
      unitRef="uref_2099918223">0.12</us-gaap:RelatedPartyTransactionRate>
    <mrai:AccruedInterest
      contextRef="cref_302890046"
      decimals="-3"
      id="ixv-7639"
      unitRef="uref_388777331">26000</mrai:AccruedInterest>
    <us-gaap:InterestExpenseDebt
      contextRef="cref_1864859878"
      decimals="-3"
      id="ixv-7640"
      unitRef="uref_388777331">18000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="cref_678316177"
      decimals="-3"
      id="ixv-7641"
      unitRef="uref_388777331">26000</us-gaap:InterestExpenseDebt>
    <us-gaap:PrepaidExpenseCurrentAndNoncurrent
      contextRef="cref_1016381307"
      decimals="-3"
      id="ixv-7642"
      unitRef="uref_388777331">500000</us-gaap:PrepaidExpenseCurrentAndNoncurrent>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="cref_1353931839"
      decimals="-3"
      id="ixv-7643"
      unitRef="uref_388777331">183000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="cref_1577086537"
      decimals="-3"
      id="ixv-7644"
      unitRef="uref_388777331">183000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="cref_765845676"
      decimals="-3"
      id="ixv-7645"
      unitRef="uref_388777331">317000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="cref_1870440128"
      decimals="-5"
      id="ixv-7646"
      unitRef="uref_388777331">1000000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:OtherLiabilities
      contextRef="cref_204867774"
      decimals="-5"
      id="ixv-7647"
      unitRef="uref_388777331">1000000</us-gaap:OtherLiabilities>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock contextRef="cref_678316177" id="ixv-4268">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&lt;span style="font-weight: bold;"&gt;NOTE 14 &#x2013; ACCRUED EXPENSES&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;Accrued expenses consisted of the following:&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;(in thousands)&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center;"&gt;June 30,&lt;/td&gt; &lt;td style="font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center;"&gt;December 31,&lt;/td&gt; &lt;td style="font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;2026&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;2025&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="width: 76%; text-align: left;"&gt;Accrued payables&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;769&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;671&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left;"&gt;Employee compensation&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;745&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;548&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: left;"&gt;Performance guarantee liabilities&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;204&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;199&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left;"&gt;Accrued bonuses&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;134&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;232&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: left; padding-bottom: 1.5pt;"&gt;Settlement liability&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;604&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;465&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left; padding-bottom: 4pt;"&gt;Accrued expenses&lt;/td&gt; &lt;td style="padding-bottom: 4pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;2,456&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 4pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;2,115&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock contextRef="cref_678316177" id="ixv-4272">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;Accrued expenses consisted of the following:&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center;"&gt;June 30,&lt;/td&gt; &lt;td style="font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center;"&gt;December 31,&lt;/td&gt; &lt;td style="font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;2026&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;2025&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="width: 76%; text-align: left;"&gt;Accrued payables&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;769&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;671&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left;"&gt;Employee compensation&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;745&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;548&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: left;"&gt;Performance guarantee liabilities&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;204&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;199&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left;"&gt;Accrued bonuses&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;134&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;232&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: left; padding-bottom: 1.5pt;"&gt;Settlement liability&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;604&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;465&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left; padding-bottom: 4pt;"&gt;Accrued expenses&lt;/td&gt; &lt;td style="padding-bottom: 4pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;2,456&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 4pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;2,115&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <mrai:AccruedPayables
      contextRef="cref_685214448"
      decimals="-3"
      id="ixv-7648"
      unitRef="uref_388777331">769000</mrai:AccruedPayables>
    <mrai:AccruedPayables
      contextRef="cref_560512737"
      decimals="-3"
      id="ixv-7649"
      unitRef="uref_388777331">671000</mrai:AccruedPayables>
    <us-gaap:AccruedEmployeeBenefitsCurrent
      contextRef="cref_685214448"
      decimals="-3"
      id="ixv-7650"
      unitRef="uref_388777331">745000</us-gaap:AccruedEmployeeBenefitsCurrent>
    <us-gaap:AccruedEmployeeBenefitsCurrent
      contextRef="cref_560512737"
      decimals="-3"
      id="ixv-7651"
      unitRef="uref_388777331">548000</us-gaap:AccruedEmployeeBenefitsCurrent>
    <mrai:PerformanceGuaranteeLiabilitiesCurrent
      contextRef="cref_685214448"
      decimals="-3"
      id="ixv-7652"
      unitRef="uref_388777331">204000</mrai:PerformanceGuaranteeLiabilitiesCurrent>
    <mrai:PerformanceGuaranteeLiabilitiesCurrent
      contextRef="cref_560512737"
      decimals="-3"
      id="ixv-7653"
      unitRef="uref_388777331">199000</mrai:PerformanceGuaranteeLiabilitiesCurrent>
    <us-gaap:AccruedBonusesCurrent
      contextRef="cref_685214448"
      decimals="-3"
      id="ixv-7654"
      unitRef="uref_388777331">134000</us-gaap:AccruedBonusesCurrent>
    <us-gaap:AccruedBonusesCurrent
      contextRef="cref_560512737"
      decimals="-3"
      id="ixv-7655"
      unitRef="uref_388777331">232000</us-gaap:AccruedBonusesCurrent>
    <mrai:SettlementLiability
      contextRef="cref_685214448"
      decimals="-3"
      id="ixv-7656"
      unitRef="uref_388777331">604000</mrai:SettlementLiability>
    <mrai:SettlementLiability
      contextRef="cref_560512737"
      decimals="-3"
      id="ixv-7657"
      unitRef="uref_388777331">465000</mrai:SettlementLiability>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="cref_685214448"
      decimals="-3"
      id="ixv-7658"
      unitRef="uref_388777331">2456000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="cref_560512737"
      decimals="-3"
      id="ixv-7659"
      unitRef="uref_388777331">2115000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="cref_678316177" id="ixv-4358">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&lt;span style="font-weight: bold;"&gt;NOTE 15 &#x2013; INCOME TAXES&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;"&gt; The effective tax rate was 0% for the three and six months ended June 30, 2026 and 2025, due primarily to the full valuation allowance on deferred tax assets and other discrete items. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;"&gt; At December 31, 2025, we had federal and state net operating losses (&#x201c;NOLs&#x201d;) in the amount of approximately $71.0 million and $57.4 million. While the federal NOLs carryforward indefinitely, the Tax Cuts &amp;amp; Jobs Act of 2017 limits the amount of federal net operating loss utilized each year after December 31, 2020 to 80% of taxable income. The state NOLs begin to expire in 2031. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;"&gt;Income tax expense is recorded using the asset and liability method. Deferred tax assets and liabilities are recognized for the expected future tax consequences attributable to temporary differences between amounts reported for income tax purposes and financial statement purposes, using current tax rates. A valuation allowance is recognized if it is anticipated that some or all of a deferred tax asset will not be realized. We must assess the likelihood that our deferred tax assets will be recovered from future taxable income and, to the extent that we believe that recovery is not likely, it must establish a valuation allowance. Significant management judgment is required in determining the provision for income taxes, deferred tax assets and liabilities and any valuation allowance recorded against net deferred tax assets.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt; At June 30, 2026 and 2025, there were $0 unrecognized tax benefits that if recognized would affect the annual effective tax rate. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;We and our subsidiaries&#x2019; income tax returns since 2022 remain subject to examination by tax jurisdictions.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;"&gt;In July 2025, the President of the United States signed into law budget reconciliation bill H.R.1, commonly referred to as the One Big Beautiful Bill Act (&#x201c;OBBBA&#x201d;) introducing tax reform measures that included changes to tax deductions for businesses, international tax rules, and foreign tax credit limitations that become effective in 2025 and 2026. As of enactment, these changes did not materially affect our deferred tax assets and liabilities or related valuation allowances. The impact on our income tax expense, effective income tax rate and cash tax payments for the year ended December 31, 2025 was not material. We will continue to evaluate the full impact of the legislation as additional guidance becomes available.&lt;/p&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="cref_678316177"
      decimals="2"
      id="ixv-7660"
      unitRef="uref_2099918223">0</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="cref_968639710"
      decimals="2"
      id="ixv-7661"
      unitRef="uref_2099918223">0</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="cref_1864859878"
      decimals="2"
      id="ixv-7662"
      unitRef="uref_2099918223">0</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="cref_696692331"
      decimals="2"
      id="ixv-7663"
      unitRef="uref_2099918223">0</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:OperatingLossCarryforwards
      contextRef="cref_1876967377"
      decimals="-5"
      id="ixv-7664"
      unitRef="uref_388777331">71000000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="cref_1318692929"
      decimals="-5"
      id="ixv-7665"
      unitRef="uref_388777331">57400000</us-gaap:OperatingLossCarryforwards>
    <mrai:MaximumPercentageOfTaxableIncomeCanBeUtilizedForOperatingLosses
      contextRef="cref_2099918223"
      decimals="2"
      id="ixv-7666"
      unitRef="uref_2099918223">0.80</mrai:MaximumPercentageOfTaxableIncomeCanBeUtilizedForOperatingLosses>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="cref_685214448"
      decimals="-3"
      id="ixv-7667"
      unitRef="uref_388777331">0</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="cref_156869995"
      decimals="-3"
      id="ixv-7668"
      unitRef="uref_388777331">0</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:LegalMattersAndContingenciesTextBlock contextRef="cref_678316177" id="ixv-4374">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&lt;span style="font-weight: bold;"&gt;NOTE 16 &#x2013; LITIGATION AND LOSS CONTINGENCIES&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;"&gt;From time to time, we may be subject to other legal proceedings, claims, investigations, and government inquiries (collectively, legal proceedings) in the ordinary course of business. We may receive claims from third parties asserting, among other things, infringement of their intellectual property rights, defamation, labor and employment rights, privacy, and contractual rights.&lt;/p&gt;          &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;"&gt; On January 30, 2025, the Company was served with a civil complaint by Messer Financial Group Inc. (&#x201c;Messer&#x201d;), a sublessee of the Company&#x2019;s previously rented office space in Charlotte, NC, for breach of contract. On July 28, 2025, the Company and the plaintiff conducted a mediation session, which was unsuccessful in resolving the dispute. On September 22, 2025, the plaintiff commenced discovery proceedings in the litigation, and in September 2025, the Company was informed that the plaintiff&#x2019;s expert indicated estimated damages in excess of $5&#160;million. On February 5, 2026, the Company agreed to a settlement agreement with Messer Financial Group Inc. pursuant to which, the Company is required to pay (i) a one-time lump sum of $10 thousand cash consideration; (ii) issue restricted shares of common stock (&#x201c;&lt;span style="text-decoration:underline"&gt;RSU&lt;/span&gt;&#x201d;) of Marpai in an amount valued at $25 thousand as consideration for Messer&#x2019;s attorney&#x2019;s fees; and (iii)&#160;400,000&#160;RSUs in installments issuable as follows: (a)&#160;100,000&#160;restricted shares of common stock within thirty (30) days of the Effective Date; (b)&#160;100,000&#160;restricted shares of common stock by July 1, 2026; (c)&#160;100,000&#160;restricted shares of common stock by January 1, 2027; and (d)&#160;100,000&#160;restricted shares of common stock by July 1, 2027. On January 3, 2028, if the Total Value (defined below) of the Stock Consideration is less than $1.0 million, Marpai will (A) pay Messer an additional $250 thousand in cash, or (B) issue Messer $250 thousand&#160;in restricted shares of common stock of Marpai (MRAI), valued in the same manner as Total Value. Total Value shall be determined by averaging Marpai&#x2019;s closing stock price on (A) the payment due date, (B) 45 days prior to the payment due date, and (C) 90 days prior to the payment due date. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;"&gt;After Messer received the Cash Consideration, Messer voluntarily dismissed the Lawsuit in its entirety as to all Defendants with prejudice.&lt;/p&gt;</us-gaap:LegalMattersAndContingenciesTextBlock>
    <us-gaap:LossContingencyDamagesSoughtValue
      contextRef="cref_247623300"
      decimals="-6"
      id="ixv-7669"
      unitRef="uref_388777331">5000000</us-gaap:LossContingencyDamagesSoughtValue>
    <us-gaap:Cash
      contextRef="cref_35673841"
      decimals="-3"
      id="ixv-7670"
      unitRef="uref_388777331">10000</us-gaap:Cash>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="cref_1329316492"
      decimals="-3"
      id="ixv-7671"
      unitRef="uref_388777331">25000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="cref_78158019"
      decimals="0"
      id="ixv-7672"
      unitRef="uref_917344505">400000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="cref_1329316492"
      decimals="0"
      id="ixv-7673"
      unitRef="uref_917344505">100000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="cref_1917496726"
      decimals="0"
      id="ixv-7674"
      unitRef="uref_917344505">100000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="cref_94216187"
      decimals="0"
      id="ixv-7675"
      unitRef="uref_917344505">100000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="cref_1444181199"
      decimals="0"
      id="ixv-7676"
      unitRef="uref_917344505">100000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="cref_1934857388"
      decimals="-5"
      id="ixv-7677"
      unitRef="uref_388777331">1000000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:Cash
      contextRef="cref_2127661120"
      decimals="-3"
      id="ixv-7678"
      unitRef="uref_388777331">250000</us-gaap:Cash>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="cref_547452146"
      decimals="-3"
      id="ixv-7679"
      unitRef="uref_388777331">250000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:SubsequentEventsTextBlock contextRef="cref_678316177" id="ixv-4397">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&lt;span style="font-weight: bold;"&gt;NOTE 17 &#x2013; SUBSEQUENT EVENTS&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;"&gt;The Company evaluated subsequent events from June 30, 2026, the date of these condensed consolidated financial statements, through August 13, 2026, the issuance date of these condensed consolidated financial statements for events requiring recognition or disclosure in the condensed consolidated financial statements.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;"&gt;On July 16, 2026, we executed an amendment to the AXA agreement. See Note 8.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; On July 29, 2026, we entered into securities purchase agreements (each, a &#x201c;Securities Purchase Agreement&#x201d;) with accredited investors relating to an offering (the &#x201c;Offering&#x201d;) and the sale of an aggregate of 12,100 shares of newly designated Series A Preferred Stock (the &#x201c;Preferred Stock&#x201d;) at a purchase price of $1.0 thousand for each share of Preferred Stock. The aggregate gross proceeds to us from the Offering were $12.1 million. We expect the Offering to close upon satisfaction of customary closing conditions. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; In conjunction with the execution of the Purchase Agreements, we and the Mitchell Family Trust II, who acted as the lead investor in the Offering, entered into a board observer agreement (the &#x201c;Board Observer Agreement&#x201d;), pursuant to which Steve Mitchell will serve as an observer to our Board. Pursuant to the Board Observer Agreement, Mr. Mitchell will be entitled to serve as a board observer for a period of two years, provided that the lead investor continues to own at least 3,000 shares of Preferred Stock. &lt;/p&gt;</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="cref_388777331"
      decimals="0"
      id="ixv-7680"
      unitRef="uref_917344505">12100</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <mrai:PurchasePrice
      contextRef="cref_388777331"
      decimals="-2"
      id="ixv-7681"
      unitRef="uref_388777331">1000</mrai:PurchasePrice>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="cref_388777331"
      decimals="-5"
      id="ixv-7682"
      unitRef="uref_388777331">12100000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="cref_917344505"
      decimals="0"
      id="ixv-7683"
      unitRef="uref_917344505">3000</us-gaap:PreferredStockSharesAuthorized>
    <ecd:Rule10b51ArrAdoptedFlag contextRef="cref_1864859878" id="ixv-7684">false</ecd:Rule10b51ArrAdoptedFlag>
    <ecd:Rule10b51ArrTrmntdFlag contextRef="cref_1864859878" id="ixv-7685">false</ecd:Rule10b51ArrTrmntdFlag>
    <ecd:NonRule10b51ArrAdoptedFlag contextRef="cref_1864859878" id="ixv-7686">false</ecd:NonRule10b51ArrAdoptedFlag>
    <ecd:NonRule10b51ArrTrmntdFlag contextRef="cref_1864859878" id="ixv-7687">false</ecd:NonRule10b51ArrTrmntdFlag>
</xbrl>
